00000000|MMI|320.97|Portugal|C0032729|[geoa]|["PO"-tx-12-"PO"-noun-0,"PO"-tx-5-"PO"-noun-0,"PO"-tx-4-"PO"-noun-0,"PO"-tx-2-"PO"-noun-0]|TX|[3896/2],[3917/2],[3963/2],[3985/2],[4008/2],[4032/2],[4053/2],[4080/2];[1993/2],[2079/2],[2118/2];[1211/2],[1311/2],[1352/2],[1569/2];[508/2],[602/2],[729/2],[802/2],[917/2]|Z01.542.727
00000000|MMI|113.56|Oral|C0442027|[spco]|["PO"-tx-12-"PO"-noun-0,"PO"-tx-5-"PO"-noun-0,"PO"-tx-4-"PO"-noun-0,"PO"-tx-2-"PO"-noun-0]|TX|[3896/2],[3917/2],[3963/2],[3985/2],[4008/2],[4032/2],[4053/2],[4080/2];[1993/2],[2079/2],[2118/2];[1211/2],[1311/2],[1352/2],[1569/2];[508/2],[602/2],[729/2],[802/2],[917/2]|
00000000|MMI|95.52|Aspirin|C0004057|[orch,phsu]|["ASA"-tx-13-"ASA"-noun-0,"ASA"-tx-12-"ASA"-noun-0,"ASA"-tx-9-"ASA"-noun-0,"ASPIRIN"-tx-5-"ASPIRIN"-noun-0,"ASPIRIN"-tx-2-"ASPIRIN"-noun-0]|TX|4662/3;3886/3;3483/3;1795/7;657/7|D02.455.426.559.389.657.410.595.176
00000000|MMI|92.17|International Normalized Ratio|C0525032|[lbpr]|["INR"-tx-17-"INR"-noun-0,"INR"-tx-13-"INR"-noun-0,"INR"-tx-11-"INR"-noun-0,"INR"-tx-7-"INR's"-noun-0,"INR"-tx-6-"INR"-noun-0,"INR"-tx-6-"INR's"-noun-0]|TX|[5179/3],[5205/3];4720/3;3648/3;2447/5;2377/3;2413/5|E01.370.225.625.115.320;E05.200.625.115.320
00000000|MMI|91.85|Mongolia|C0026410|[geoa]|["MG"-tx-20-"Mg"-noun-0,"MG"-tx-12-"MG"-noun-0,"MG"-tx-5-"MG"-noun-0,"MG"-tx-4-"MG"-noun-0]|TX|5488/2;[3893/2],[3960/2],[4029/2],[4050/2],[4077/2];[1990/2],[2115/2];[1208/2],[1349/2]|Z01.252.474.651
00000000|MMI|71.42|Togo|C0040363|[geoa]|["TO"-tx-24-"to"-adv-0,"TO"-tx-23-"to"-adv-0,"TO"-tx-20-"to"-adv-0,"TO"-tx-15-"to"-adv-0,"TO"-tx-6-"to"-adv-0]|TX|6048/2;5985/2;5624/2;4833/2;[2381/2],[2419/2]|Z01.058.290.190.800
00000000|MMI|71.42|Tryptophanase|C0041260|[aapp,enzy]|["TO"-tx-24-"to"-adv-0,"TO"-tx-23-"to"-adv-0,"TO"-tx-20-"to"-adv-0,"TO"-tx-15-"to"-adv-0,"TO"-tx-6-"to"-adv-0]|TX|6048/2;5985/2;5624/2;4833/2;[2381/2],[2419/2]|D08.811.520.224.800
00000000|MMI|64.02|Patient Discharge|C0030685|[hlca]|["Discharge"-tx-28-"DISCHARGE"-noun-0,"Discharge"-tx-26-"DISCHARGE"-noun-0,"Discharge"-tx-7-"DISCHARGE"-noun-0,"Discharge"-tx-1-"DISCHARGE"-noun-0,"Patient Discharge"-tx-1-"DISCHARGE PATIENT"-noun-0]|TX|6283/9;6122/9;2564/9;175/9;252/17|E02.204.125;E02.760.400.610;N02.421.192.125;N02.421.585.400.610;N04.590.233.727.210.125
00000000|MMI|63.93|3,4-Methylenedioxyamphetamine|C0000379|[orch,phsu]|["MDA"-tx-5-"mda"-noun-0,"MDA"-tx-4-"mda"-noun-0,"MDA"-tx-3-"mda"-noun-0,"MDA"-tx-2-"mda"-noun-0]|TX|1839/3;[1178/3],[1678/3];1020/3;701/3|D02.092.471.683.152.660
00000000|MMI|58.89|Coumadin|C0699129|[orch,phsu]|["Coumadin"-tx-12-"Coumadin"-noun-0,"Coumadin"-tx-11-"Coumadin"-noun-0,"Coumadin"-tx-4-"COUMADIN"-noun-0,"Coumadin"-tx-2-"COUMADIN"-noun-0]|TX|3949/8;3611/8;1318/8;593/8|D03.383.663.283.446.520.914;D03.438.150.446.520.914
00000000|MMI|56.82|Obesity|C0028754|[dsyn]|["OBESE"-tx-12-"obese"-adj-0,"OBESITY"-tx-7-"obesity"-noun-0]|TX|4231/5;[2757/7],[2767/7]|C18.654.726.500;C23.888.144.699.500;E01.370.600.115.100.160.120.699.500;G07.100.100.160.120.699.500
00000000|MMI|50.15|Override|C1547671|[acty]|["Override"-tx-5-"override"-verb-0,"Override"-tx-4-"Override"-verb-0,"Override"-tx-4-"override"-verb-0,"Override"-tx-3-"Override"-verb-0,"Override"-tx-3-"overridden"-noun-0,"Override"-tx-3-"override"-verb-0,"Override"-tx-2-"Override"-verb-0,"Override"-tx-2-"overridden"-noun-0,"Override"-tx-2-"override"-verb-0]|TX|1829/8;[1476/8],[1493/8],[1713/8];[1168/8],[1668/8],[1691/8];1050/8;1039/10;1010/8;[514/8],[531/8],[847/8];835/10;691/8|
00000000|MMI|44.38|Cerebroside-Sulfatase|C0007804|[aapp,enzy]|["ASA"-tx-13-"ASA"-noun-0,"ASA"-tx-12-"ASA"-noun-0,"ASA"-tx-9-"ASA"-noun-0]|TX|4662/3;3886/3;3483/3|D08.811.277.352.827.070.250
00000000|MMI|43.93|Coding|C0009219|[ocac]|["code"-tx-20-"Code"-noun-0,"code"-tx-2-"CODE"-noun-0,"code"-tx-2-"code"-noun-0]|TX|5582/4;416/4;434/4|N04.452.758.708.200.400.500;N04.452.859.564.274;N05.715.360.300.715.500.249;N06.850.520.308.940.968.249
00000000|MMI|43.90|Warfarin|C0043031|[hops,orch,phsu]|["WARFARIN"-tx-5-"WARFARIN"-noun-0,"WARFARIN"-tx-4-"WARFARIN"-noun-0,"WARFARIN"-tx-2-"WARFARIN"-noun-0]|TX|1809/8;1624/8;671/8|D03.383.663.283.446.520.914;D03.438.150.446.520.914
00000000|MMI|43.31|phosphoethanolamine|C0070939|[bacs,orch]|["PE"-tx-17-"PE"-noun-0,"PE"-tx-13-"PE"-noun-0,"PE"-tx-12-"PE"-noun-0,"PE"-tx-11-"PE's"-noun-0]|TX|[5137/2],[5168/2];4705/2;3725/2;3603/4|x.x.x.x
00000000|MMI|43.05|Heparin|C0019134|[bacs,orch,phsu]|["HEPARIN"-tx-20-"Heparin"-noun-0,"HEPARIN"-tx-17-"Heparin"-noun-0,"HEPARIN"-tx-13-"Heparin"-noun-0,"HEPARIN"-tx-11-"Heparin"-noun-0]|TX|5547/7;[5151/7],[5283/7];4682/7;3587/7|D09.698.373.400
00000000|MMI|43.04|Moldova|C0026374|[geoa]|["MDA"-tx-5-"mda"-noun-0,"MDA"-tx-4-"mda"-noun-0,"MDA"-tx-3-"mda"-noun-0,"MDA"-tx-2-"mda"-noun-0]|TX|1839/3;[1178/3],[1678/3];1020/3;701/3|Z01.542.248.540;Z01.586.200.540;Z01.586.950.540
00000000|MMI|42.50|Dominican Republic|C0013014|[geoa]|["DR"-tx-24-"Dr"-noun-0,"DR"-tx-6-"Dr"-noun-0,"DR"-tx-5-"Dr"-noun-0,"DR"-tx-1-"Dr"-noun-0]|TX|6097/2;2341/2;2307/2;236/2|Z01.107.084.900.300;Z01.639.880.300
00000000|MMI|42.43|Pain|C0030193|[sosy]|["PAIN"-tx-12-"pain"-noun-0,"PAIN"-tx-10-"pain"-noun-0,"PAIN"-tx-4-"Pain"-noun-0,"PAIN"-tx-2-"Pain"-noun-0]|TX|4091/4;3493/4;1222/4;740/4|C10.597.617;C23.888.592.612;F02.830.816.444;G11.561.600.810.444
00000000|MMI|34.21|Physicians|C0031831|[prog]|["DR"-tx-24-"Dr"-noun-0,"DR"-tx-6-"Dr"-noun-0,"DR"-tx-5-"Dr"-noun-0,"DR"-tx-1-"Dr"-noun-0]|TX|6097/2;2341/2;2307/2;236/2|M01.526.485.810;N02.360.810
00000000|MMI|31.80|Ventral Hernia|C0019326|[anab]|["Hernia, ventral"-tx-12-"Ventral Hernia"-noun-0,"Hernia, ventral"-tx-12-"ventral hernia"-noun-1,"Hernia, ventral"-tx-7-"ventral hernia"-noun-0]|TX|3837/14;4404/14;2877/14|C23.300.707.374.937
00000000|MMI|31.38|Penicillins|C0030842|[antb,orch]|["Penicillin"-tx-12-"Penicillin"-noun-0,"PENICILLINS"-tx-7-"Penicillins"-noun-0]|TX|4107/10;2497/11|D02.065.589.099.750;D02.886.108.750;D03.438.260.825;D03.605.084.737;D04.075.080.875.099.221.750
00000000|MMI|31.38|diagnosis aspect|C1704338|[qlco]|["diagnosis"-tx-7-"DIAGNOSIS"-noun-0]|TX|[2523/9],[2659/9]|x.x.x.x.x.x.x
00000000|MMI|29.31|Angina, Unstable|C0002965|[dsyn]|["Angina, Unstable"-tx-7-"unstable angina"-noun-0]|TX|[2918/15],[3165/15]|C10.597.617.192.500.150;C14.280.647.187.150;C14.907.585.187.150;C23.888.592.612.233.500.150
00000000|MMI|25.85|Sarcoidosis|C0036202|[dsyn]|["SARCOIDOSIS"-tx-12-"Sarcoidosis"-noun-0,"Sarcoid"-tx-7-"sarcoid"-noun-0]|TX|3746/11;[2781/7],[2795/7]|C15.604.515.827
00000000|MMI|25.45|Gastroesophageal reflux disease|C0017168|[dsyn]|["GERD"-tx-17-"GERD"-noun-0,"GERD"-tx-12-"GERD"-noun-0]|TX|5296/4;3830/4|C06.405.117.119.500.484
00000000|MMI|25.36|Daily|C0332173|[tmco]|["QD"-tx-12-"QD"-noun-0,"QD"-tx-5-"QD"-noun-0,"QD"-tx-2-"QD"-noun-0]|TX|[3899/2],[3920/2],[3966/2],[3988/2],[4035/2];[1892/2],[1996/2],[2121/2];[511/2],[805/2]|
00000000|MMI|25.15|Flonase|C0286677|[orch,phsu]|["Flonase"-tx-12-"Flonase"-noun-0,"Flonase"-tx-5-"FLONASE"-noun-0]|TX|3925/7;1843/7|D04.808.054.079.129.114
00000000|MMI|24.59|Magnesium Cation|C2346927|[elii,phsu]|["Mg++"-tx-20-"Mg"-noun-0,"Mg++"-tx-12-"MG"-noun-0,"Mg++"-tx-5-"MG"-noun-0,"Mg++"-tx-4-"MG"-noun-0]|TX|5488/2;[3893/2],[3960/2],[4029/2],[4050/2],[4077/2];[1990/2],[2115/2];[1208/2],[1349/2]|
00000000|MMI|24.59|Milligram percent|C1960952|[qnco]|["mg %"-tx-20-"Mg"-noun-0,"mg %"-tx-12-"MG"-noun-0,"mg %"-tx-5-"MG"-noun-0,"mg %"-tx-4-"MG"-noun-0]|TX|5488/2;[3893/2],[3960/2],[4029/2],[4050/2],[4077/2];[1990/2],[2115/2];[1208/2],[1349/2]|
00000000|MMI|24.59|mg/dL|C0439269|[qnco]|["mg%"-tx-20-"Mg"-noun-0,"mg%"-tx-12-"MG"-noun-0,"mg%"-tx-5-"MG"-noun-0,"mg%"-tx-4-"MG"-noun-0]|TX|5488/2;[3893/2],[3960/2],[4029/2],[4050/2],[4077/2];[1990/2],[2115/2];[1208/2],[1349/2]|
00000000|MMI|24.54|Doctor of Medicine|C1512018|[inpr]|["M.D."-tx-27-"M.D"-noun-0,"M.D."-tx-4-"M.D"-noun-0,"M.D."-tx-3-"M.D"-noun-0,"M.D."-tx-2-"M.D"-noun-0,"M.D."-tx-1-"M.D"-noun-0]|TX|6242/3;[1537/3],[1757/3];1094/3;[575/3],[891/3];411/3|
00000000|MMI|21.35|Proton Pump Inhibitors|C0358591|[phsu]|["PPI"-tx-20-"PPI"-noun-0,"PPI"-tx-17-"PPI"-noun-0]|TX|5541/3;5309/3|D27.505.519.389.848
00000000|MMI|21.35|prepulse inhibition activity|C0871125|[phsf]|["PPI"-tx-20-"PPI"-noun-0,"PPI"-tx-17-"PPI"-noun-0]|TX|5541/3;5309/3|G11.561.600.812.500
00000000|MMI|21.21|Lesotho|C0023376|[geoa]|["LT"-tx-5-"lt"-noun-0,"LT"-tx-2-"lt"-noun-0]|TX|2013/2;822/2|Z01.058.290.175.400
00000000|MMI|21.09|Exercise stress test|C0015260|[diap]|["stress test"-tx-21-"stress test"-noun-0,"stress test"-tx-15-"stress test"-noun-0]|TX|5726/11;4779/11|E01.370.370.380.250;E01.370.386.700.250;E05.333.250
00000000|MMI|21.09|Stress Test|C3494508|[diap]|["Stress Test"-tx-21-"stress test"-noun-0,"Stress Test"-tx-15-"stress test"-noun-0]|TX|5726/11;4779/11|E01.370.370.380.250;E01.370.386.700.250;E05.333.250
00000000|MMI|21.04|Diovan|C0719949|[orch,phsu]|["Diovan"-tx-12-"Diovan"-noun-0,"Diovan"-tx-5-"DIOVAN"-noun-0]|TX|4040/6;1966/6|D03.383.129.617.850;D12.125.070.950.550;D12.125.142.930.500
00000000|MMI|20.79|To|C1883351|[qlco]|["To"-tx-24-"to"-adv-0,"To"-tx-23-"to"-adv-0,"To"-tx-20-"to"-adv-0,"To"-tx-15-"to"-adv-0,"To"-tx-6-"to"-adv-0]|TX|6048/2;5985/2;5624/2;4833/2;[2381/2],[2419/2]|
00000000|MMI|19.95|Hypertensive disease|C0020538|[dsyn]|["HTN"-tx-12-"HTN"-noun-0,"HTN"-tx-7-"htn"-noun-0,"HYPERTENSION"-tx-7-"hypertension"-noun-0]|TX|3696/3;2736/3;2742/12|C14.907.489
00000000|MMI|19.75|Obesity, Morbid|C0028756|[dsyn]|["Morbid Obesity"-tx-12-"morbid obesity"-noun-0]|TX|3702/14|C18.654.726.500.700;C23.888.144.699.500.500;E01.370.600.115.100.160.120.699.500.500;G07.100.100.160.120.699.500.500
00000000|MMI|19.38|Physical Examination|C0031809|[hlca]|["PHYSICAL EXAM"-tx-16-"physical exam"-noun-0,"PHYSICAL EXAM"-tx-12-"PHYSICAL EXAM"-noun-0,"Physical"-tx-8-"physical"-adj-0]|TX|4940/13;4162/13;3311/8|E01.370.600
00000000|MMI|19.29|Food|C0016452|[food]|["FOODS"-tx-4-"foods"-noun-0,"Food"-tx-4-"Food"-noun-0,"Food"-tx-4-"food"-noun-0]|TX|1470/5;1227/4;1271/4|G07.203.300;J02.500
00000000|MMI|19.16|Tablet Dosage Form|C0039225|[bodm]|["TAB"-tx-12-"TAB"-noun-0,"TAB"-tx-4-"TAB"-noun-0,"TAB"-tx-2-"TAB"-noun-0]|TX|3981/3;1307/3;798/3|D26.255.830
00000000|MMI|17.70|Cacao Plant|C0006622|[plnt]|["chocolate"-tx-22-"chocolate"-noun-0]|TX|5852/9|B01.650.940.800.575.100.915.144
00000000|MMI|17.70|Chocolate|C0008299|[food]|["Chocolate"-tx-22-"chocolate"-noun-0]|TX|5852/9|B01.650.940.800.575.100.915.144
00000000|MMI|17.70|Naproxen|C0027396|[orch,phsu]|["NAPROXEN"-tx-4-"NAPROXEN"-noun-0]|TX|1193/8|D02.455.426.559.847.638.472.500;D04.615.638.472.450
00000000|MMI|17.70|Penicillin G|C0030827|[antb,orch]|["penicillin"-tx-12-"Penicillin"-noun-0]|TX|4107/10|D02.065.589.099.750.750;D02.886.108.750.750;D03.438.260.825.750;D03.605.084.737.750;D04.075.080.875.099.221.750.750
00000000|MMI|17.70|Sennosides|C3489575|[phsu]|["Sennosides"-tx-4-"SENNOSIDES"-noun-0]|TX|1292/10|D02.455.426.559.847.117.159.750;D02.806.100.750;D20.215.784.500.860
00000000|MMI|17.48|Integrated Neuromusculoskeletal Release|C1704538|[topp]|["INR"-tx-17-"INR"-noun-0,"INR"-tx-13-"INR"-noun-0,"INR"-tx-11-"INR"-noun-0,"INR"-tx-7-"INR's"-noun-0,"INR"-tx-6-"INR"-noun-0,"INR"-tx-6-"INR's"-noun-0]|TX|[5179/3],[5205/3];4720/3;3648/3;2447/5;2377/3;2413/5|
00000000|MMI|17.24|Mental Depression|C0011570|[mobd]|["DEPRESSION"-tx-7-"depression"-noun-0]|TX|[2892/10],[2905/10]|F01.145.126.350
00000000|MMI|17.22|Infantile Neuroaxonal Dystrophy|C0270724|[dsyn]|["PLAN"-tx-26-"PLAN"-noun-0,"PLAN"-tx-23-"plan"-verb-0]|TX|6156/4;5980/4|C10.228.140.744
00000000|MMI|17.19|Single-Stranded Conformational Polymorphism|C0243031|[lbtr]|["SSCP"-tx-8-"SSCP"-noun-1,"SSCP"-tx-7-"SSCP"-noun-0]|TX|3379/4;3218/4|G05.365.795.600
00000000|MMI|17.16|Alces alces|C0325226|[mamm]|["Moose"-tx-4-"MOOSE"-noun-0,"Moose"-tx-3-"MOOSE"-noun-0,"Moose"-tx-2-"MOOSE"-noun-0]|TX|[1522/5],[1742/5];1079/5;[560/5],[876/5]|
00000000|MMI|17.16|bucking|C0852885|[inpo]|["buck"-tx-4-"BUCK"-noun-0,"buck"-tx-3-"BUCK"-noun-0,"buck"-tx-2-"BUCK"-noun-0]|TX|[1530/4],[1750/4];1087/4;[568/4],[884/4]|
00000000|MMI|16.95|Solomon Islands|C0037623|[geoa]|["BP"-tx-16-"BP"-noun-0,"BP"-tx-12-"BP"-noun-0]|TX|5069/2;4194/2|Z01.639.760.590
00000000|MMI|16.86|Oxygen|C0030054|[elii,phsu]|["O2"-tx-14-"O2"-noun-0,"O2"-tx-12-"O2"-noun-0]|TX|4726/2;4212/2|D01.268.185.550;D01.362.670;x.x.x.x
00000000|MMI|16.83|Triamterene|C0040869|[orch,phsu]|["TRIAMTERENE"-tx-4-"TRIAMTERENE"-noun-0,"TRIAMTERENE"-tx-2-"TRIAMTERENE"-noun-0]|TX|1145/11;755/11|D03.438.733.900
00000000|MMI|16.82|Discipline of Nuclear Medicine|C0028582|[bmod]|["Nuclear Medicine"-tx-23-"nuclear medicine"-noun-0,"Nuclear Medicine"-tx-5-"Nuclear Medicine"-noun-0]|TX|5953/16;2276/16|H02.403.740.500
00000000|MMI|16.82|Radionuclide Imaging|C0034606|[diap]|["Nuclear medicine"-tx-23-"nuclear medicine"-noun-0,"Nuclear medicine"-tx-5-"Nuclear Medicine"-noun-0]|TX|5953/16;2276/16|E01.370.350.710;E01.370.384.730
00000000|MMI|16.73|Naprosyn|C0700017|[orch,phsu]|["Naprosyn"-tx-4-"NAPROSYN"-noun-0]|TX|1182/8|D02.455.426.559.847.638.472.500;D04.615.638.472.450
00000000|MMI|16.60|Vitamin K|C0042878|[orch,vita]|["VITAMIN K"-tx-4-"Vitamin-K"-noun-0]|TX|1449/9|D02.455.426.559.847.638.721.374;D02.455.849.291.523.500;D04.615.638.721.374;x.x.x.x
00000000|MMI|16.57|history of - * (non-specific)|C0455483|[fndg]|["h o"-tx-17-"h/o"-noun-0,"h o"-tx-17-"h/o"-noun-1,"h o"-tx-11-"h/o"-noun-0,"h o"-tx-7-"H/O"-noun-0,"h o"-tx-7-"h/o"-noun-0]|TX|[5164/3],[5234/3],[5292/3];[5164/3],[5234/3],[5292/3];3599/3;2791/3;[2777/3],[3125/3]|
00000000|MMI|15.65|Cerebellum|C0007765|[bpoc]|["Cerebellar"-tx-12-"cerebellar"-adj-0]|TX|3789/10|A08.186.211.132.810.428.200
00000000|MMI|15.65|Penicillin|C0220892|[antb,orch]|["PENICILLIN"-tx-12-"Penicillin"-noun-0]|TX|4107/10|D02.065.589.099.750;D02.886.108.750;D03.438.260.825;D03.605.084.737;D04.075.080.875.099.221.750
00000000|MMI|15.65|Surgical aspects|C0038895|[ftcn]|["operations"-tx-7-"OPERATIONS"-noun-0]|TX|2945/10|x.x.x.x.x.x.x
00000000|MMI|15.65|Warfarin Sodium|C0376218|[hops,orch,phsu]|["WARFARIN SODIUM"-tx-4-"WARFARIN SODIUM"-noun-0]|TX|1329/15|D03.383.663.283.446.520.914;D03.438.150.446.520.914
00000000|MMI|14.96|Diverticulosis|C1510475|[anab,dsyn]|["DIVERTICULOSIS"-tx-7-"diverticulosis"-noun-0]|TX|[2843/14],[2860/14]|C23.300.415
00000000|MMI|14.96|Polyarthritis|C0162323|[dsyn]|["POLYARTHRITIS"-tx-12-"polyarthritis"-noun-0,"Polyarticular Arthritis"-tx-7-"polyarticular arthritis"-noun-0]|TX|3730/13;2817/23|C05.550.114
00000000|MMI|14.91|Negation|C1518422|[ftcn]|["Not"-tx-22-"not"-adv-0,"Non"-tx-12-"non"-adj-0,"Not"-tx-8-"not"-adv-0,"Not"-tx-7-"NOT"-adv-0]|TX|[5771/3],[5825/3];4463/3;[3345/3],[3393/3];3007/3|
00000000|MMI|14.71|Order (action)|C1705178|[acty]|["Order"-tx-28-"ORDERS"-verb-0,"Order"-tx-4-"order"-noun-0,"Order"-tx-2-"order"-noun-0,"Order"-tx-1-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|6293/6;1545/5;[583/5],[899/5];334/5;185/6|
00000000|MMI|14.71|Order (arrangement)|C1705176|[qlco]|["Order"-tx-28-"ORDERS"-verb-0,"Order"-tx-4-"order"-noun-0,"Order"-tx-2-"order"-noun-0,"Order"-tx-1-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|6293/6;1545/5;[583/5],[899/5];334/5;185/6|
00000000|MMI|14.71|Order (document)|C1705175|[inpr]|["Order"-tx-28-"ORDERS"-verb-0,"Order"-tx-4-"order"-noun-0,"Order"-tx-2-"order"-noun-0,"Order"-tx-1-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|6293/6;1545/5;[583/5],[899/5];334/5;185/6|
00000000|MMI|14.71|Order (taxonomic)|C1705177|[clas]|["Order"-tx-28-"ORDERS"-verb-0,"Order"-tx-4-"order"-noun-0,"Order"-tx-2-"order"-noun-0,"Order"-tx-1-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|6293/6;1545/5;[583/5],[899/5];334/5;185/6|
00000000|MMI|14.71|Permutation|C1882348|[qlco]|["Order"-tx-28-"ORDERS"-verb-0,"Order"-tx-4-"order"-noun-0,"Order"-tx-2-"order"-noun-0,"Order"-tx-1-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|6293/6;1545/5;[583/5],[899/5];334/5;185/6|
00000000|MMI|14.71|Sequence of Planned Assessment Schedule|C3889825|[inpr]|["ORDER"-tx-28-"ORDERS"-verb-0,"ORDER"-tx-4-"order"-noun-0,"ORDER"-tx-2-"order"-noun-0,"ORDER"-tx-1-"ORDER"-noun-0,"ORDER"-tx-1-"ORDERS"-verb-0]|TX|6293/6;1545/5;[583/5],[899/5];334/5;185/6|
00000000|MMI|14.68|Chimerin 1|C0067895|[aapp,bacs]|["NC"-tx-14-"NC"-noun-0]|TX|4729/2|D12.644.360.325.150.100.200;D12.776.476.325.150.100.200;D12.776.641.124.200
00000000|MMI|14.54|therapeutic aspects|C0039798|[ftcn]|["treatment"-tx-7-"Treatment"-noun-0]|TX|2721/9|x.x.x.x.x.x.x
00000000|MMI|13.60|Angina Pectoris|C0002962|[fndg]|["ANGINA"-tx-7-"angina"-noun-0]|TX|2936/6|C10.597.617.192.500;C14.280.647.187;C14.907.585.187;C23.888.592.612.233.500
00000000|MMI|13.60|Risk|C0035647|[idcn]|["Risk"-tx-15-"risk"-verb-0]|TX|4836/4|E05.318.740.600.800;G17.680.750;N05.715.360.750.625.700;N06.850.520.830.600.800
00000000|MMI|13.60|Vision|C0042789|[orgf]|["see"-tx-26-"see"-verb-0]|TX|6169/3|F02.830.816.964;G02.111.087.800.480.900;G02.149.115.800.480.900;G04.299.880.480.900;G11.561.600.810.964;G14.640.816
00000000|MMI|13.14|Depressive disorder|C0011581|[mobd]|["-- Depression"-tx-7-"depression"-noun-0]|TX|[2892/10],[2905/10]|F03.600.300
00000000|MMI|13.14|Disease|C0012634|[dsyn]|["condition"-tx-26-"CONDITION"-noun-0,"condition"-tx-7-"Conditions"-noun-0]|TX|6132/9;2669/10|C23.550.288
00000000|MMI|12.97|Drawings (art)|C0013113|[inpr]|["Draw"-tx-6-"drawn"-verb-0]|TX|[2387/5],[2425/5]|V01.185.625;V02.700.300
00000000|MMI|12.92|Appointments|C0003629|[idcn]|["Appointment"-tx-24-"appointment"-noun-0,"Appointment"-tx-5-"APPOINTMENT"-noun-0]|TX|6036/11;2258/11|N04.452.095
00000000|MMI|12.92|objective (goal)|C0018017|[inpr]|["Goal"-tx-17-"goal"-noun-0]|TX|[5193/4],[5209/4]|F01.658.500
00000000|MMI|12.73|Pharmacology|C0031330|[bmod]|["Pharmacologic"-tx-21-"pharmacologic"-adj-0,"Pharmacologic"-tx-15-"pharmacologic"-adj-0]|TX|5712/13;4765/13|H01.158.703;H02.628
00000000|MMI|12.63|North Carolina|C0028407|[geoa]|["NC"-tx-14-"NC"-noun-0]|TX|4729/2|Z01.107.567.875.075.475;Z01.107.567.875.750.530
00000000|MMI|12.59|Activated Partial Thromboplastin Time measurement|C0030605|[lbpr]|["PTT"-tx-17-"ptt"-noun-0]|TX|5189/3|E01.370.225.625.115.600;E05.200.625.115.600;G09.188.660
00000000|MMI|12.57|Caffeine|C0006644|[orch,phsu]|["CAFFEINE"-tx-22-"caffeine"-noun-0]|TX|5879/8|D03.132.960.175;D03.438.759.758.824.175
00000000|MMI|12.56|Weaning|C0043084|[fndg]|["Weaned"-tx-14-"weaned"-verb-0]|TX|4732/6|G07.203.650.220.500.750;G07.203.650.593.762;G07.700.620.762
00000000|MMI|12.53|District of Columbia|C0012764|[geoa]|["D.C."-tx-1-"D/C"-noun-0]|TX|330/3|Z01.107.567.875.500.210;Z01.433.429
00000000|MMI|12.50|Ciprofloxacin Hydrochloride|C0282104|[antb,orch]|["ciprofloxacin hcl"-tx-4-"CIPROFLOXACIN HCL"-noun-0]|TX|1639/17|D03.438.810.835.322.186
00000000|MMI|12.50|fluticasone|C0082607|[orch,phsu]|["FLUTICASONE"-tx-5-"FLUTICASONE"-noun-0]|TX|1853/11|D04.808.054.079.129.114
00000000|MMI|12.47|Ciprofloxacin|C0008809|[orch,phsu]|["CIPROFLOXACIN"-tx-4-"CIPROFLOXACIN"-noun-0]|TX|1555/13|D03.438.810.835.322.186
00000000|MMI|12.32|Hospital admission|C0184666|[hlca]|["Admit"-tx-12-"ADMIT"-verb-0,"admitted"-tx-12-"admitted"-verb-0,"admitted"-tx-11-"admitted"-verb-0,"Admission"-tx-7-"Admission"-noun-0,"Admit"-tx-7-"ADMIT"-verb-0]|TX|4156/5;4588/8;3556/8;2621/9;2517/5|
00000000|MMI|11.90|Indication of (contextual qualifier)|C0392360|[idcn]|["Reason"-tx-5-"Reason"-noun-0,"Reason"-tx-4-"Reason"-noun-0,"Reason"-tx-3-"Reason"-noun-0,"Reason"-tx-2-"Reason"-noun-0]|TX|1818/6;[1157/6],[1657/6];999/6;680/6|
00000000|MMI|11.90|Interaction|C1704675|[ftcn]|["Interaction"-tx-5-"INTERACTION"-noun-0,"Interaction"-tx-4-"INTERACTION"-noun-0,"Interaction"-tx-4-"Interaction"-noun-0,"Interaction"-tx-2-"INTERACTION"-noun-0]|TX|1782/11;[1107/11],[1611/11];1237/11;644/11|
00000000|MMI|11.78|Additional|C1524062|[ftcn]|["Added"-tx-4-"added"-verb-0,"Added"-tx-3-"added"-verb-0,"Added"-tx-2-"added"-verb-0]|TX|[1502/5],[1722/5];1059/5;[540/5],[856/5]|
00000000|MMI|11.76|Now (temporal qualifier)|C1948052|[tmco]|["Now"-tx-18-"now"-adv-0,"Now"-tx-17-"now"-adv-0,"Now"-tx-11-"now"-adv-0,"Now"-tx-4-"NOW"-adv-0]|TX|[5383/3],[5429/3];5183/3;3652/3;1368/3|
00000000|MMI|11.70|heparin, porcine|C0770546|[bacs,orch,phsu]|["HEPARIN"-tx-20-"Heparin"-noun-0,"HEPARIN"-tx-17-"Heparin"-noun-0,"HEPARIN"-tx-13-"Heparin"-noun-0,"HEPARIN"-tx-11-"Heparin"-noun-0]|TX|5547/7;[5151/7],[5283/7];4682/7;3587/7|
00000000|MMI|11.61|Home environment|C0442519|[cnce]|["HOME"-tx-20-"home"-noun-0,"HOME"-tx-16-"home"-noun-0,"HOME"-tx-13-"home"-noun-0,"house"-tx-5-"House"-noun-0,"HOME"-tx-2-"Home"-noun-0]|TX|5637/4;5036/4;4635/4;2130/5;452/4|
00000000|MMI|11.56|Alopecia|C0002170|[dsyn]|["ALOPECIA"-tx-2-"ALOPECIA"-noun-0]|TX|988/8|C17.800.329.937.122;C23.300.035
00000000|MMI|11.56|Asthma|C0004096|[dsyn]|["-- Asthma"-tx-12-"asthma"-noun-0]|TX|3821/6|C08.127.108;C08.381.495.108;C08.674.095;C20.543.480.680.095
00000000|MMI|11.56|Cerebrovascular accident|C0038454|[dsyn]|["CVA, NOS"-tx-12-"CVA"-noun-0]|TX|3777/3|C10.228.140.300.775;C14.907.253.855
00000000|MMI|11.56|Chest Pain|C0008031|[sosy]|["CHEST PAIN"-tx-7-"chest pain"-noun-0]|TX|3063/10|C10.597.617.192;C23.888.592.612.233
00000000|MMI|11.56|Colonic Polyps|C0009376|[anab]|["Colonic Polyps"-tx-12-"colonic polyps"-noun-0]|TX|3804/14|C23.300.825.411.235
00000000|MMI|11.56|valsartan|C0216784|[orch,phsu]|["VALSARTAN"-tx-5-"VALSARTAN"-noun-0]|TX|1975/9|D03.383.129.617.850;D12.125.070.950.550;D12.125.142.930.500
00000000|MMI|10.65|Fat-Restricted Diet|C0242970|[topp]|["low fat"-tx-5-"Low fat"-noun-0]|TX|2174/3,2188/3|E02.642.249.260;G07.203.650.240.260
00000000|MMI|10.58|Eating|C0013470|[orgf]|["Eat"-tx-22-"eat"-noun-0]|TX|5775/3|G07.203.650.593.260;G07.700.620.260;G10.261.326.240
00000000|MMI|10.58|Ivory Coast|C0022326|[geoa]|["IV"-tx-20-"IV"-noun-0]|TX|5555/2|Z01.058.290.190.272
00000000|MMI|10.58|New Caledonia|C0027964|[geoa]|["NC"-tx-14-"NC"-noun-0]|TX|4729/2|Z01.639.760.590.620
00000000|MMI|10.58|Respiratory rate|C0231832|[clna]|["RESP"-tx-12-"Resp"-noun-0]|TX|4376/4|E01.370.600.875.875;G09.772.770.755.730
00000000|MMI|10.50|Antihypertensive Agents|C0003364|[phsu]|["ANTIHYPERTENSIVES"-tx-16-"antihypertensives"-noun-0]|TX|5041/17|D27.505.954.411.162
00000000|MMI|10.49|Barbados|C0004739|[geoa]|["BB"-tx-13-"BB"-noun-0]|TX|4651/2|Z01.107.084.900.140;Z01.639.880.140
00000000|MMI|10.49|Treatment Protocols|C0040808|[topp]|["Regimen"-tx-13-"regimen"-noun-0]|TX|4640/7|E02.183;N05.715.360.775.225
00000000|MMI|10.49|Potassium Chloride|C0032825|[inch,phsu]|["POTASSIUM CHLORIDE"-tx-4-"POTASSIUM CHLORIDE"-noun-0]|TX|1120/18|D01.210.450.150.750;D01.745.625
00000000|MMI|10.47|Guaiac|C0018302|[irda,orch]|["GUAIAC"-tx-17-"guaiac"-noun-0]|TX|5263/6|D20.215.721.500.490
00000000|MMI|10.45|Deep Vein Thrombosis|C0149871|[dsyn]|["DVT NOS"-tx-12-"DVT"-noun-0]|TX|3719/3|C14.907.355.830.925
00000000|MMI|10.45|Fluorides|C0016327|[inch,phsu]|["F-"-tx-6-"f"-noun-0]|TX|2409/1|D01.248.497.158.380;D01.303.350.300
00000000|MMI|10.45|Slow-K|C0700918|[inch,phsu]|["Slow-K"-tx-12-"Slow-k"-noun-0]|TX|3904/6|D01.210.450.150.750;D01.745.625
00000000|MMI|10.43|Food-Drug Interactions|C0242785|[dsyn]|["Interaction, Food-Drug"-tx-4-"Food/Drug Interaction"-noun-0]|TX|1407/21|G07.690.773.968.511
00000000|MMI|9.93|Entity Name Part Type - given|C1550718|[idcn]|["given"-tx-17-"Given"-adj-0,"given"-tx-13-"given"-verb-0,"given"-tx-12-"Given"-verb-0,"given"-tx-9-"given"-verb-0]|TX|5228/5;4690/5;4542/5;3467/5|
00000000|MMI|9.93|GIVEN|C1442162|[cnce]|["GIVEN"-tx-17-"Given"-adj-0,"GIVEN"-tx-13-"given"-verb-0,"GIVEN"-tx-12-"Given"-verb-0,"GIVEN"-tx-9-"given"-verb-0]|TX|5228/5;4690/5;4542/5;3467/5|
00000000|MMI|9.93|Give - dosing instruction imperative|C1947971|[ftcn]|["Given"-tx-17-"Given"-adj-0,"Given"-tx-13-"given"-verb-0,"Given"-tx-12-"Given"-verb-0,"Given"-tx-9-"given"-verb-0]|TX|5228/5;4690/5;4542/5;3467/5|
00000000|MMI|9.93|Given name|C3244317|[inpr]|["given"-tx-17-"Given"-adj-0,"given"-tx-13-"given"-verb-0,"given"-tx-12-"Given"-verb-0,"given"-tx-9-"given"-verb-0]|TX|5228/5;4690/5;4542/5;3467/5|
00000000|MMI|9.51|Coffee|C0009237|[food]|["Coffee"-tx-22-"coffee"-noun-0]|TX|5834/6|D20.215.784.249;G07.203.100.325;J02.200.325
00000000|MMI|9.51|Diverticulitis|C0012813|[dsyn]|["DIVERTICULITIS"-tx-12-"Diverticulitis"-noun-0]|TX|3760/14|C01.539.463.298;C06.405.205.298
00000000|MMI|9.51|Hypoxia|C0242184|[patf]|["HYPOXIA"-tx-17-"hypoxia"-noun-1]|TX|5113/7|C23.888.852.079
00000000|MMI|9.51|pantoprazole|C0081876|[orch,phsu]|["PANTOPRAZOLE"-tx-5-"PANTOPRAZOLE"-noun-0]|TX|2097/12|x.x.x.x
00000000|MMI|9.51|sennosides, USP|C0074332|[orch,phsu]|["SENNOSIDES"-tx-4-"SENNOSIDES"-noun-0]|TX|1292/10|x.x.x.x
00000000|MMI|9.32|Delayed Release Dosage Form|C1707664|[bodm]|["DR"-tx-24-"Dr"-noun-0,"DR"-tx-6-"Dr"-noun-0,"DR"-tx-5-"Dr"-noun-0,"DR"-tx-1-"Dr"-noun-0]|TX|6097/2;2341/2;2307/2;236/2|
00000000|MMI|9.32|Device to Subject Relationship Domain|C3540849|[inpr]|["DR"-tx-24-"Dr"-noun-0,"DR"-tx-6-"Dr"-noun-0,"DR"-tx-5-"Dr"-noun-0,"DR"-tx-1-"Dr"-noun-0]|TX|6097/2;2341/2;2307/2;236/2|
00000000|MMI|9.32|Doctor - Title|C2348314|[cnce]|["Dr."-tx-24-"Dr"-noun-0,"Dr."-tx-6-"Dr"-noun-0,"Dr."-tx-5-"Dr"-noun-0,"Dr."-tx-1-"Dr"-noun-0]|TX|6097/2;2341/2;2307/2;236/2|
00000000|MMI|9.32|Body Fluid Discharge|C0012621|[bdsu]|["Discharge"-tx-28-"DISCHARGE"-noun-0,"Discharge"-tx-26-"DISCHARGE"-noun-0,"Discharge"-tx-7-"DISCHARGE"-noun-0,"Discharge"-tx-1-"DISCHARGE"-noun-0]|TX|6283/9;6122/9;2564/9;175/9|
00000000|MMI|9.32|Discharge, body substance|C2926602|[bdsu]|["Discharge"-tx-28-"DISCHARGE"-noun-0,"Discharge"-tx-26-"DISCHARGE"-noun-0,"Discharge"-tx-7-"DISCHARGE"-noun-0,"Discharge"-tx-1-"DISCHARGE"-noun-0]|TX|6283/9;6122/9;2564/9;175/9|
00000000|MMI|9.31|+5|C0728893|[qnco]|["+5"-tx-20-"5"-integer-0,"+5"-tx-10-"5"-integer-0,"+5"-tx-5-"5"-integer-0,"+5"-tx-4-"5"-integer-0]|TX|5477/1;3514/1;2062/1;1347/1|
00000000|MMI|9.31|>5|C0439084|[qnco]|[">5"-tx-20-"5"-integer-0,">5"-tx-10-"5"-integer-0,">5"-tx-5-"5"-integer-0,">5"-tx-4-"5"-integer-0]|TX|5477/1;3514/1;2062/1;1347/1|
00000000|MMI|9.26|Pain NOS Adverse Event|C1962977|[fndg]|["Pain NOS"-tx-12-"pain"-noun-0,"Pain NOS"-tx-10-"pain"-noun-0,"Pain NOS"-tx-4-"Pain"-noun-0,"Pain NOS"-tx-2-"Pain"-noun-0]|TX|4091/4;3493/4;1222/4;740/4|
00000000|MMI|9.25|4+ Answer to question|C3838679|[fndg]|["4+"-tx-9-"4"-integer-0,"4+"-tx-5-"4"-integer-0,"4+"-tx-1-"4"-fraction-0]|TX|3473/1;1964/1;[111/1],[152/1]|
00000000|MMI|9.16|Serious|C0205404|[qlco]|["Serious"-tx-5-"SERIOUS"-adj-0,"Serious"-tx-4-"SERIOUS"-adj-0,"Serious"-tx-2-"SERIOUS"-adj-0]|TX|1774/7;[1099/7],[1603/7];636/7|
00000000|MMI|8.50|Influenza|C0021400|[dsyn]|["FLU"-tx-20-"Flu"-noun-0]|TX|5559/3|C02.782.620.365;C08.730.310
00000000|MMI|8.48|Diet|C0012155|[food]|["Diet"-tx-5-"DIET"-noun-0]|TX|2124/4|G07.203.650.240
00000000|MMI|8.46|Rabbi|C0684010|[prog]|["R."-tx-7-"R"-noun-0]|TX|3016/1|M01.526.799.500
00000000|MMI|8.45|Desiccation|C0011682|[npop]|["Dry"-tx-16-"dry"-adj-0]|TX|4925/3|E05.196.335;G02.149.767.530;G02.842.750.530
00000000|MMI|8.45|doxorubicin/mitomycin/vinblastine protocol|C0052712|[topp]|["MVA"-tx-8-"MVA"-noun-0]|TX|3261/3|x.x.x.x
00000000|MMI|8.44|Dilatation and Curettage|C0012358|[topp]|["D & C"-tx-1-"D/C"-noun-0]|TX|330/3|E04.157.310;E04.950.300.299
00000000|MMI|8.41|A(2)C|C0050322|[orch]|["c 2"-tx-7-"c 2"-noun-0]|TX|3185/1,3209/1|x.x.x.x
00000000|MMI|8.39|Gentamicin Sulfate (USP)|C0546866|[antb,orch]|["GM"-tx-5-"gm"-noun-0]|TX|2140/2|D09.408.051.374
00000000|MMI|8.38|Automobiles|C0004381|[mnob]|["Car"-tx-1-"CAR"-noun-0]|TX|248/3|J01.937.500.100
00000000|MMI|8.38|Panama|C0030266|[geoa]|["PM"-tx-1-"PM"-adj-0]|TX|291/2|Z01.107.169.772
00000000|MMI|7.46|Arthritis|C0003864|[dsyn]|["ARTHRITIS"-tx-7-"arthritis"-noun-0]|TX|2805/9|C05.550.114
00000000|MMI|7.46|Complication Aspects|C1171258|[patf]|["complications"-tx-7-"Complications"-noun-0]|TX|2695/13|x.x.x
00000000|MMI|7.46|Ischemia|C0022116|[patf]|["Ischaemia, NOS"-tx-12-"Ischemia"-noun-1]|TX|4532/8|C23.550.513
00000000|MMI|7.46|Kidney|C0022646|[bpoc]|["Renal"-tx-18-"Renal"-adj-0]|TX|5318/5|A05.810.453
00000000|MMI|7.46|Methods aspects|C0025664|[inpr]|["procedures"-tx-7-"PROCEDURES"-noun-0]|TX|2960/10|x.x.x
00000000|MMI|7.46|Neurology speciality|C0027855|[bmod]|["NEURO"-tx-12-"Neuro"-adj-0]|TX|4448/5|H02.403.600
00000000|MMI|7.27|Arylsulfatase A, human|C3853627|[aapp,enzy]|["ASA"-tx-13-"ASA"-noun-0,"ASA"-tx-12-"ASA"-noun-0,"ASA"-tx-9-"ASA"-noun-0]|TX|4662/3;3886/3;3483/3|
00000000|MMI|7.22|ALYREF gene|C1425988|[gngm]|["REF"-tx-4-"ref"-noun-0,"REF"-tx-2-"ref"-noun-0]|TX|1574/3;[607/3],[922/3]|
00000000|MMI|7.14|Continuous|C0549178|[idcn]|["Continue"-tx-20-"continue"-verb-0,"Continued"-tx-16-"continued"-verb-0,"Continued"-tx-13-"continued"-verb-0]|TX|5615/8;5019/9;4618/9|
00000000|MMI|7.07|Admission activity|C0809949|[hlca]|["Admitted"-tx-12-"admitted"-verb-0,"Admitted"-tx-11-"admitted"-verb-0,"Admission"-tx-7-"Admission"-noun-0]|TX|4588/8;3556/8;2621/9|
00000000|MMI|7.05|Atypical chest pain|C0262384|[sosy]|["ATYPICAL CHEST PAIN"-tx-7-"atypical chest pain"-noun-0,"ATYPICAL CHEST PAIN"-tx-1-"atypical chest pain"-noun-0]|TX|[2534/19],[2633/19];65/19|
00000000|MMI|6.97|Not Applicable|C1272460|[qlco]|["{NA}"-tx-5-"NA"-noun-0,"{NA}"-tx-5-"Na"-noun-0,"NOT APPLICABLE"-tx-1-"Not Applicable"-adj-0]|TX|1889/2;2143/2;310/14|
00000000|MMI|6.97|Package Type Not Applicable|C4049872|[ftcn]|["NA"-tx-5-"NA"-noun-0,"NA"-tx-5-"Na"-noun-0,"Not Applicable"-tx-1-"Not Applicable"-adj-0]|TX|1889/2;2143/2;310/14|
00000000|MMI|6.87|80%|C3842583|[fndg]|["80%"-tx-17-"80"-integer-0,"80%"-tx-12-"80"-integer-0,"80%"-tx-5-"80"-integer-0]|TX|5201/2;4047/2;1987/2|
00000000|MMI|6.86|Pyrexia of unknown origin (excl puerperal)|C0856281|[sosy]|["puo"-tx-23-"PUO"-noun-0,"puo"-tx-11-"PUO"-noun-0,"puo"-tx-1-"PUO"-noun-0]|TX|5937/3;3526/3;12/3|
00000000|MMI|6.83|Maxzide|C0127096|[orch,phsu]|["Maxzide"-tx-12-"Maxzide"-noun-0,"Maxzide"-tx-2-"MAXZIDE"-noun-0]|TX|3971/7;[745/7],[909/7]|
00000000|MMI|6.82|Code|C0805701|[inpr]|["CODE"-tx-20-"Code"-noun-0,"CODE"-tx-2-"CODE"-noun-0,"CODE"-tx-2-"code"-noun-0]|TX|5582/4;416/4;434/4|
00000000|MMI|6.82|eTMF Content Model Code|C3889831|[inpr]|["Code"-tx-20-"Code"-noun-0,"Code"-tx-2-"CODE"-noun-0,"Code"-tx-2-"code"-noun-0]|TX|5582/4;416/4;434/4|
00000000|MMI|6.81|Low Mitosis-Karyorrhexis Index|C3890211|[qnco]|["Low"-tx-17-"low"-adj-0,"Low"-tx-5-"Low"-adj-0]|TX|[5123/3],[5175/3];2174/3|
00000000|MMI|6.81|low|C0205251|[qlco]|["Low"-tx-17-"low"-adj-0,"Low"-tx-5-"Low"-adj-0]|TX|[5123/3],[5175/3];2174/3|
00000000|MMI|6.81|low confidentiality|C1550472|[inpr]|["low"-tx-17-"low"-adj-0,"low"-tx-5-"Low"-adj-0]|TX|[5123/3],[5175/3];2174/3|
00000000|MMI|6.81|low exposure|C4048187|[qlco]|["low"-tx-17-"low"-adj-0,"low"-tx-5-"Low"-adj-0]|TX|[5123/3],[5175/3];2174/3|
00000000|MMI|6.80|100%|C3817553|[qnco]|["100%"-tx-11-"100"-percentage-0,"100%"-tx-5-"100"-integer-0,"100%"-tx-2-"100"-integer-0]|TX|3548/3;2016/3;825/3|
00000000|MMI|6.79|Tablet Dosing Unit|C1705223|[qnco]|["Tab"-tx-12-"TAB"-noun-0,"Tab"-tx-4-"TAB"-noun-0,"Tab"-tx-2-"TAB"-noun-0]|TX|3981/3;1307/3;798/3|
00000000|MMI|6.75|Approximate|C0332232|[qlco]|["Approximate"-tx-5-"approximate"-adj-0]|TX|[1949/11],[2047/11]|
00000000|MMI|6.75|CR2 wt Allele|C3539604|[gngm]|["CR"-tx-19-"Cr"-noun-0,"CR"-tx-18-"Cr"-noun-0]|TX|5452/2;5359/2|
00000000|MMI|6.75|Cardiovascular System Findings Domain|C3538987|[idcn]|["CV"-tx-12-"CV"-noun-0]|TX|[4338/2],[4528/2]|
00000000|MMI|6.75|Creatinine measurement|C0201975|[lbpr]|["Cr"-tx-19-"Cr"-noun-0,"Cr"-tx-18-"Cr"-noun-0]|TX|5452/2;5359/2|
00000000|MMI|6.75|Diagnosis|C0011900|[fndg]|["DIAGNOSIS"-tx-7-"DIAGNOSIS"-noun-0]|TX|[2523/9],[2659/9]|E01
00000000|MMI|6.75|Diagnosis Study|C1704656|[resa]|["DIAGNOSIS"-tx-7-"DIAGNOSIS"-noun-0]|TX|[2523/9],[2659/9]|
00000000|MMI|6.75|Hold (action)|C1948035|[acty]|["Hold"-tx-5-"HOLD"-verb-0,"Hold"-tx-2-"HOLD"-verb-0]|TX|1999/4;808/4|
00000000|MMI|6.75|Hold - dosing instruction fragment|C1553387|[idcn]|["Hold"-tx-5-"HOLD"-verb-0,"Hold"-tx-2-"HOLD"-verb-0]|TX|1999/4;808/4|
00000000|MMI|6.75|Obesity Adverse Event|C1963185|[fndg]|["Obesity"-tx-7-"obesity"-noun-0]|TX|[2757/7],[2767/7]|
00000000|MMI|6.75|Requirement|C1514873|[ftcn]|["Required"-tx-5-"Required"-verb-0]|TX|[1938/8],[2036/8]|
00000000|MMI|6.75|hold - Data Operation|C3853841|[ftcn]|["hold"-tx-5-"HOLD"-verb-0,"hold"-tx-2-"HOLD"-verb-0]|TX|1999/4;808/4|
00000000|MMI|6.75|orders - HL7PublishingDomain|C3244315|[inpr]|["orders"-tx-28-"ORDERS"-verb-0,"orders"-tx-1-"ORDERS"-verb-0]|TX|6293/6;185/6|
00000000|MMI|6.75|sulfa|C0749139|[phsu]|["sulfa"-tx-12-"Sulfa"-noun-0,"sulfa"-tx-7-"Sulfa"-noun-0]|TX|4120/5;2511/5|
00000000|MMI|6.49|Abdomen|C0000726|[blor]|["abd"-tx-12-"Abd"-noun-0]|TX|4387/3|A01.923.047
00000000|MMI|6.49|teratologic|C0000769|[ftcn]|["abnormalities"-tx-15-"abnormalities"-noun-0]|TX|4891/13|x.x.x
00000000|MMI|6.44|polyps|C0032584|[anab]|["POLYPS"-tx-17-"polyps"-noun-0]|TX|5238/6|C23.300.825
00000000|MMI|6.44|Diet therapy|C0012159|[hlca]|["Diet"-tx-5-"DIET"-noun-0]|TX|2124/4|E02.642.249
00000000|MMI|6.43|Nonprofit Organizations|C0029247|[orgt]|["NPO"-tx-20-"NPO"-noun-0]|TX|5508/3|N03.540.630
00000000|MMI|6.41|Diagnostic Imaging|C0011923|[diap]|["Imaging"-tx-15-"imaging"-verb-0]|TX|4798/7|E01.370.350
00000000|MMI|6.41|Hospitals|C0019994|[hcro,mnob]|["HOSPITAL"-tx-20-"hospital"-noun-0]|TX|5685/8|N02.278.421
00000000|MMI|6.41|Outpatients|C0029921|[podg]|["Outpatient"-tx-15-"outpatient"-noun-0]|TX|4812/10|M01.643.630
00000000|MMI|6.41|Allergy Specialty|C0002111|[bmod]|["Allergy"-tx-7-"ALLERGY"-noun-0]|TX|2488/7|H02.403.044
00000000|MMI|6.36|Heart failure|C0018801|[dsyn]|["Failure, Heart"-tx-16-"heart failure"-noun-1]|TX|4976/13|C14.280.434
00000000|MMI|6.34|Germany|C0017480|[geoa]|["GM"-tx-5-"gm"-noun-0]|TX|2140/2|Z01.542.315;Z01.586.315
00000000|MMI|6.32|Education, Pharmacy|C0013642|[edac]|["Pharmacy Instruction"-tx-4-"Pharmacy Instruction"-noun-0]|TX|1389/8,1429/11|I02.358.525
00000000|MMI|5.41|Feces|C0015733|[bdsu]|["Stools"-tx-17-"stools"-noun-0]|TX|5251/6|A12.459
00000000|MMI|5.41|Head|C0018670|[blor]|["HEAD"-tx-8-"head"-noun-0]|TX|3353/4|A01.456
00000000|MMI|5.41|Infection|C3714514|[patf]|["Infections"-tx-7-"Infections"-noun-0]|TX|2682/10|C01.539
00000000|MMI|5.41|Patients|C0030705|[podg]|["*^patient"-tx-16-"Patient"-noun-0]|TX|4913/7|M01.643
00000000|MMI|4.93|Heparin-induced thrombocytopenia|C0272285|[dsyn]|["HIT"-tx-8-"hit"-noun-0,"HIT"-tx-8-"hit"-verb-1]|TX|[3290/3],[3349/3];[3290/3],[3349/3]|
00000000|MMI|4.93|Hit - database search return|C1708373|[ftcn]|["HIT"-tx-8-"hit"-noun-0,"HIT"-tx-8-"hit"-verb-0]|TX|[3290/3],[3349/3];[3290/3],[3349/3]|
00000000|MMI|4.93|Struck by|C0332159|[ftcn]|["hit"-tx-8-"hit"-noun-0,"hit"-tx-8-"hit"-verb-0]|TX|[3290/3],[3349/3];[3290/3],[3349/3]|
00000000|MMI|4.92|Condition|C0348080|[qlco]|["Condition"-tx-26-"CONDITION"-noun-0,"Condition"-tx-7-"Conditions"-noun-0]|TX|6132/9;2669/10|
00000000|MMI|4.92|Condition:Find:Pt:^Patient:Nom|C3864998|[clna]|["Condition"-tx-26-"CONDITION"-noun-0,"Condition"-tx-7-"Conditions"-noun-0]|TX|6132/9;2669/10|
00000000|MMI|4.92|Control function|C2587213|[ftcn]|["Control"-tx-16-"control"-noun-0,"Controlled"-tx-5-"Controlled"-verb-0]|TX|5072/7;2161/10|
00000000|MMI|4.92|Depressed mood|C0344315|[fndg]|["depression"-tx-7-"depression"-noun-0]|TX|[2892/10],[2905/10]|
00000000|MMI|4.92|Depression Scale (BASC-2)|C4049644|[inpr]|["Depression"-tx-7-"depression"-noun-0]|TX|[2892/10],[2905/10]|
00000000|MMI|4.92|Depression motion|C0460137|[ftcn]|["Depression"-tx-7-"depression"-noun-0]|TX|[2892/10],[2905/10]|
00000000|MMI|4.92|Logical Condition|C1705253|[cnce]|["Condition"-tx-26-"CONDITION"-noun-0,"Condition"-tx-7-"Conditions"-noun-0]|TX|6132/9;2669/10|
00000000|MMI|4.92|Pixels per Inch|C3811894|[idcn]|["PPI"-tx-20-"PPI"-noun-0,"PPI"-tx-17-"PPI"-noun-0]|TX|5541/3;5309/3|
00000000|MMI|4.90|Planned|C1301732|[ftcn]|["Plan"-tx-26-"PLAN"-noun-0,"Plan"-tx-23-"plan"-verb-0]|TX|6156/4;5980/4|
00000000|MMI|4.90|Treatment Plan|C0599880|[inpr]|["Plan"-tx-26-"PLAN"-noun-0,"Plan"-tx-23-"plan"-verb-0]|TX|6156/4;5980/4|
00000000|MMI|4.89|Followed by|C0332283|[tmco]|["follow"-tx-18-"follow"-verb-0,"Followed by"-tx-7-"followed by"-verb-0]|TX|5364/6;2461/11|
00000000|MMI|4.87|Instruction [Publication Type]|C0302828|[inpr]|["instructions"-tx-26-"instructions"-noun-0,"Instruction"-tx-4-"Instruction"-noun-0]|TX|6173/12;1249/11|
00000000|MMI|4.87|Instructions|C1442085|[idcn]|["Instructions"-tx-26-"instructions"-noun-0,"instruction"-tx-4-"Instruction"-noun-0]|TX|6173/12;1249/11|
00000000|MMI|4.84|Right|C0205090|[spco]|["RIGHT"-tx-12-"right"-noun-0,"R-"-tx-7-"R"-noun-0]|TX|3783/5;3016/1|
00000000|MMI|4.83|Take|C1515187|[hlca]|["Take"-tx-20-"take"-verb-0,"Take"-tx-4-"Take"-verb-0]|TX|5627/4;1261/4|
00000000|MMI|4.82|Involvement with|C1314939|[ftcn]|["Involved"-tx-8-"involved"-verb-0,"Affecting"-tx-7-"affecting"-verb-0]|TX|3233/8;2711/9|
00000000|MMI|4.79|Lymphotoxin-Alpha, human|C3887647|[aapp,imft]|["LT"-tx-5-"lt"-noun-0,"LT"-tx-2-"lt"-noun-0]|TX|2013/2;822/2|
00000000|MMI|4.79|Structure of left thigh|C0230426|[bpoc]|["LT"-tx-5-"lt"-noun-0,"LT"-tx-2-"lt"-noun-0]|TX|2013/2;822/2|
00000000|MMI|4.73|Medical History|C0262926|[fndg]|["Hx"-tx-13-"hx"-noun-0,"PMH"-tx-12-"PMH"-noun-0]|TX|4700/2;3691/3|
00000000|MMI|4.73|Equine sarcoid of skin|C3668957|[dsyn]|["Sarcoid"-tx-7-"sarcoid"-noun-0]|TX|[2781/7],[2795/7]|
00000000|MMI|4.72|1+|C3816745|[fndg]|["1+"-tx-12-"1"-integer-0,"1+"-tx-2-"1"-integer-0]|TX|4524/1;796/1|
00000000|MMI|4.72|1+ Score|C2827734|[qnco]|["1+"-tx-12-"1"-integer-0,"1+"-tx-2-"1"-integer-0]|TX|4524/1;796/1|
00000000|MMI|4.72|1+ Score, WHO|C2981698|[clas]|["1+"-tx-12-"1"-integer-0,"1+"-tx-2-"1"-integer-0]|TX|4524/1;796/1|
00000000|MMI|4.72|Act Relationship Subset - previous|C1552607|[tmco]|["previous"-tx-4-"Previous"-adj-0,"previous"-tx-3-"Previous"-adj-0]|TX|1682/8;1024/8|
00000000|MMI|4.72|Previous|C0205156|[tmco]|["Previous"-tx-4-"Previous"-adj-0,"Previous"-tx-3-"Previous"-adj-0]|TX|1682/8;1024/8|
00000000|MMI|4.72|Physical Exam Domain|C1744699|[inpr]|["Physical Exam"-tx-16-"physical exam"-noun-0,"Physical Exam"-tx-12-"PHYSICAL EXAM"-noun-0]|TX|4940/13;4162/13|
00000000|MMI|4.70|Act Mood - Goal|C1571704|[idcn]|["Goal"-tx-17-"goal"-noun-0]|TX|[5193/4],[5209/4]|
00000000|MMI|4.70|Hospital course|C0489547|[fndg]|["Hospital course"-tx-12-"HOSPITAL COURSE"-noun-1,"Hospital course"-tx-7-"HOSPITAL COURSE"-noun-1]|TX|4507/15;3042/15|
00000000|MMI|4.70|Hospital course:Finding:Point in time:^Patient:Narrative|C0488549|[clna]|["Hospital course"-tx-12-"HOSPITAL COURSE"-noun-0,"Hospital course"-tx-7-"HOSPITAL COURSE"-noun-0]|TX|4507/15;3042/15|
00000000|MMI|4.70|Summary (document)|C1706244|[inpr]|["Summary"-tx-26-"summary"-noun-0,"Summary"-tx-1-"SUMMARY"-noun-0]|TX|6198/7;359/7|
00000000|MMI|4.70|summary - ActRelationshipSubset|C1552616|[inpr]|["summary"-tx-26-"summary"-noun-0,"summary"-tx-1-"SUMMARY"-noun-0]|TX|6198/7;359/7|
00000000|MMI|4.69|/hour|C0564385|[qnco]|["/hour"-tx-10-"hour"-noun-0,"/hour"-tx-4-"Hour"-noun-0]|TX|3516/4;1381/4|
00000000|MMI|4.69|Hour|C0439227|[tmco]|["HOUR"-tx-10-"hour"-noun-0,"HOUR"-tx-4-"Hour"-noun-0]|TX|3516/4;1381/4|
00000000|MMI|4.68|Bolus Dosing Unit|C1705509|[qnco]|["{Bolus}"-tx-18-"bolus"-noun-0,"{Bolus}"-tx-16-"bolused"-verb-0]|TX|5423/5;4995/7|
00000000|MMI|4.68|Radiotherapy Bolus|C3812160|[medd]|["Bolus"-tx-18-"bolus"-noun-0,"Bolus"-tx-16-"bolused"-verb-0]|TX|5423/5;4995/7|
00000000|MMI|4.68|bolus infusion|C1511237|[topp]|["Bolus"-tx-18-"bolus"-noun-0,"Bolus"-tx-16-"bolused"-verb-0]|TX|5423/5;4995/7|
00000000|MMI|4.67|Dose number|C1115464|[qnco]|["Dose number"-tx-5-"Number Doses"-noun-0]|TX|[1922/6,1932/5],[2020/6,2030/5]|
00000000|MMI|4.67|Dose number:Number:Point in time:^Patient:Quantitative|C1114758|[clna]|["Dose number"-tx-5-"Number Doses"-noun-0]|TX|[1922/6,1932/5],[2020/6,2030/5]|
00000000|MMI|4.65|Done (qualifier value)|C1272695|[qlco]|["Done"-tx-21-"done"-aux-0,"Done"-tx-8-"done"-aux-0]|TX|5738/4;3327/4|
00000000|MMI|4.63|HP gene|C1415692|[gngm]|["Bp"-tx-16-"BP"-noun-0,"Bp"-tx-12-"BP"-noun-0]|TX|5069/2;4194/2|
00000000|MMI|4.63|HP wt Allele|C1708288|[gngm]|["BP"-tx-16-"BP"-noun-0,"BP"-tx-12-"BP"-noun-0]|TX|5069/2;4194/2|
00000000|MMI|4.58|Three times daily|C0556984|[tmco]|["TID"-tx-12-"TID"-noun-0,"TID"-tx-4-"TID"-noun-0]|TX|3880/3;1214/3|
00000000|MMI|4.58|three times a day at institution-specified times|C1610169|[tmco]|["TID"-tx-12-"TID"-noun-0,"TID"-tx-4-"TID"-noun-0]|TX|3880/3;1214/3|
00000000|MMI|4.58|Protonix|C0876139|[orch,phsu]|["Protonix"-tx-12-"Protonix"-noun-0,"Protonix"-tx-5-"PROTONIX"-noun-0]|TX|4017/8;2086/8|
00000000|MMI|4.57|Therapeutic procedure|C0087111|[topp]|["Therapeutic"-tx-11-"therapeutic"-adj-0,"Treatment"-tx-7-"Treatment"-noun-0]|TX|3636/11;2721/9|E02
00000000|MMI|4.56|Atenolol 25 MG|C0983888|[clnd]|["Atenolol 25 MG"-tx-12-"Atenolol 25 MG"-noun-0,"Atenolol 25 MG"-tx-5-"ATENOLOL 25 MG"-noun-0]|TX|3993/14;2064/14|
00000000|MMI|4.56|Clinical Study Follow-up|C3274571|[hlca]|["FOLLOW-UP"-tx-24-"follow-up"-adj-0,"FOLLOW-UP"-tx-5-"FOLLOW UP"-adj-0]|TX|6026/9;2248/9|
00000000|MMI|4.56|Follow-Up Report|C1704685|[inpr]|["Follow-Up"-tx-24-"follow-up"-adj-0,"Follow-Up"-tx-5-"FOLLOW UP"-adj-0]|TX|6026/9;2248/9|
00000000|MMI|4.56|Follow-up status|C0589120|[fndg]|["Follow-up"-tx-24-"follow-up"-adj-0,"Follow-up"-tx-5-"FOLLOW UP"-adj-0]|TX|6026/9;2248/9|
00000000|MMI|4.56|follow-up|C1522577|[hlca]|["Follow Up"-tx-24-"follow-up"-adj-0,"Follow Up"-tx-5-"FOLLOW UP"-adj-0]|TX|6026/9;2248/9|
00000000|MMI|4.56|Curriculum Vitae|C1880201|[inpr]|["Resume"-tx-7-"RESUME"-noun-0,"Resume"-tx-5-"Resume"-noun-0]|TX|3032/6;2224/6|
00000000|MMI|4.56|Resume - Remote control command|C1550028|[idcn]|["Resume"-tx-7-"RESUME"-noun-0,"Resume"-tx-5-"Resume"-noun-0]|TX|3032/6;2224/6|
00000000|MMI|4.56|resume - DataOperation|C3242342|[ftcn]|["resume"-tx-7-"RESUME"-noun-0,"resume"-tx-5-"Resume"-noun-0]|TX|3032/6;2224/6|
00000000|MMI|4.56|Food allergenic extracts|C3540798|[imft,phsu]|["food"-tx-4-"Food"-noun-0,"food"-tx-4-"food"-noun-0]|TX|1227/4;1271/4|
00000000|MMI|4.55|Discontinued|C1444662|[fndg]|["D/C"-tx-1-"D/C"-noun-1,"DIS"-tx-1-"DIS"-noun-0]|TX|330/3;89/3|
00000000|MMI|4.52|Alert|C3665546|[ftcn]|["Alert"-tx-3-"Alert"-adj-0,"Alert"-tx-2-"Alert"-adj-0]|TX|1033/5;829/5|
00000000|MMI|4.52|Alert:Type:Point in time:^Patient:Nominal|C3669039|[clna]|["Alert"-tx-3-"Alert"-adj-0,"Alert"-tx-2-"Alert"-adj-0]|TX|1033/5;829/5|
00000000|MMI|4.52|Consciousness clear|C0239110|[fndg]|["ALERT"-tx-3-"Alert"-adj-0,"ALERT"-tx-2-"Alert"-adj-0]|TX|1033/5;829/5|
00000000|MMI|4.52|Full|C0443225|[qlco]|["Full"-tx-20-"Full"-adj-0,"Full"-tx-2-"Full"-adj-0]|TX|5577/4;429/4|
00000000|MMI|4.51|pharmacological|C0205464|[ftcn]|["Pharmacologic"-tx-21-"pharmacologic"-adj-0,"Pharmacologic"-tx-15-"pharmacologic"-adj-0]|TX|5712/13;4765/13|
00000000|MMI|4.50|/40|C0439509|[tmco]|["/40"-tx-12-"40"-integer-0,"/40"-tx-5-"40"-integer-0]|TX|4026/2;2112/2|
00000000|MMI|4.50|40%|C3842587|[qnco]|["40%"-tx-12-"40"-integer-0,"40%"-tx-5-"40"-integer-0]|TX|4026/2;2112/2|
00000000|MMI|4.50|No Application Type|C1546968|[idcn]|["NA"-tx-5-"NA"-noun-0,"NA"-tx-5-"Na"-noun-0]|TX|1889/2;2143/2|
00000000|MMI|4.50|Sodium Cation|C0597484|[elii]|["Na+"-tx-5-"NA"-noun-0,"Na+"-tx-5-"Na"-noun-0]|TX|1889/2;2143/2|
00000000|MMI|4.50|Spray (action)|C2003858|[ftcn]|["Spray"-tx-12-"SPRAY"-noun-0,"Spray"-tx-5-"SPRAY"-noun-0]|TX|3937/5;1883/5|
00000000|MMI|4.50|Spray Dosing Unit|C1704413|[qnco]|["{Spray}"-tx-12-"SPRAY"-noun-0,"{Spray}"-tx-5-"SPRAY"-noun-0]|TX|3937/5;1883/5|
00000000|MMI|4.50|Nuclear medicine procedure|C0203634|[diap]|["Nuclear medicine"-tx-23-"nuclear medicine"-noun-0,"Nuclear medicine"-tx-5-"Nuclear Medicine"-noun-0]|TX|5953/16;2276/16|
00000000|MMI|4.44|Congenital Abnormality|C0000768|[cgab]|["Abnormalities"-tx-15-"abnormalities"-noun-0]|TX|4891/13|C16.131
00000000|MMI|4.41|Neck|C0027530|[blor]|["NECK"-tx-12-"Neck"-noun-0]|TX|4291/4|A01.598
00000000|MMI|4.39|Bed rest|C0004910|[topp]|["Bed Rest"-tx-12-"resting bed"-noun-0]|TX|4251/7,4262/3|E02.075
00000000|MMI|4.38|Educational process of instructing|C0039401|[edac]|["Instruction"-tx-4-"Instruction"-noun-0]|TX|1249/11|I02.903
00000000|MMI|4.36|Allergic Reaction|C1527304|[patf]|["Allergy"-tx-7-"ALLERGY"-noun-0]|TX|2488/7|C20.543
00000000|MMI|4.36|Hypersensitivity|C0020517|[patf]|["ALLERGY"-tx-7-"ALLERGY"-noun-0]|TX|2488/7|C20.543
00000000|MMI|4.32|Perfusion (procedure)|C0031001|[topp]|["Perfusion"-tx-15-"perfusion"-noun-0]|TX|4881/9|E05.680
00000000|MMI|4.30|Heart|C0018787|[bpoc]|["Cardiac"-tx-12-"cardiac"-adj-0]|TX|4562/7|A07.541
00000000|MMI|4.29|Catheterization|C0007430|[topp]|["Catheterization"-tx-7-"catheterization"-noun-0]|TX|3193/15|E02.148;E05.157
00000000|MMI|4.27|Woman|C0043210|[popg]|["WOMAN"-tx-7-"woman"-noun-0]|TX|3116/5|M01.975
00000000|MMI|3.36|*Activity (kind of quantity)|C1561536|[idcn]|["*Activity"-tx-5-"ACTIVITY"-noun-0]|TX|2214/8|
00000000|MMI|3.36|3+ Answer to Question|C3838680|[fndg]|["3+"-tx-17-"3"-integer-0]|TX|5220/1|
00000000|MMI|3.36|3+ Score|C2827736|[qnco]|["3+"-tx-17-"3"-integer-0]|TX|5220/1|
00000000|MMI|3.36|3+ Score, WHO|C2981702|[clas]|["3+"-tx-17-"3"-integer-0]|TX|5220/1|
00000000|MMI|3.36|<3 (qualifier value)|C0439086|[qnco]|["<3"-tx-17-"3"-integer-0]|TX|5220/1|
00000000|MMI|3.36|Abortion consent:Finding:Point in time:^Patient:Document|C2360836|[clna]|["Patient"-tx-16-"Patient"-noun-0]|TX|4913/7|
00000000|MMI|3.36|ActInformationPrivacyReason <operations>|C3244305|[ftcn]|["operations"-tx-7-"OPERATIONS"-noun-0]|TX|2945/10|
00000000|MMI|3.36|Active|C0205177|[ftcn]|["Activity"-tx-5-"ACTIVITY"-noun-0]|TX|2214/8|
00000000|MMI|3.36|Activities|C0441655|[acty]|["ACTIVITY"-tx-5-"ACTIVITY"-noun-0]|TX|2214/8|
00000000|MMI|3.36|Activity (animal life circumstance)|C3668946|[fndg]|["Activity"-tx-5-"ACTIVITY"-noun-0]|TX|2214/8|
00000000|MMI|3.36|Affecting|C0392760|[ftcn]|["Affecting"-tx-7-"affecting"-verb-0]|TX|2711/9|
00000000|MMI|3.36|Aspects of signs|C0220912|[ftcn]|["signs"-tx-16-"signs"-noun-0]|TX|4959/5|
00000000|MMI|3.36|Asthma Pathway|C2984299|[ftcn]|["Asthma"-tx-12-"asthma"-noun-0]|TX|3821/6|
00000000|MMI|3.36|BESTROPHINOPATHY, AUTOSOMAL RECESSIVE|C3888198|[dsyn]|["ARB"-tx-13-"ARB"-noun-0]|TX|4656/3|
00000000|MMI|3.36|Before|C0332152|[tmco]|["BEFORE"-tx-20-"before"-adv-0]|TX|5664/6|
00000000|MMI|3.36|Before - dosing instruction fragment|C1705850|[inpr]|["Before"-tx-20-"before"-adv-0]|TX|5664/6|
00000000|MMI|3.36|Bruit|C0006318|[fndg]|["bruits"-tx-12-"bruits"-noun-1]|TX|4315/6|
00000000|MMI|3.36|C-Circle|C3538933|[celc]|["CC"-tx-7-"CC"-noun-0]|TX|3059/2|
00000000|MMI|3.36|Chest pain:Finding:Point in time:^Patient:Ordinal|C2926613|[clna]|["Chest pain"-tx-7-"chest pain"-noun-0]|TX|3063/10|
00000000|MMI|3.36|Chocolate Flavor|C1337204|[food]|["CHOCOLATE"-tx-22-"chocolate"-noun-0]|TX|5852/9|
00000000|MMI|3.36|Coffee Flavor|C1365948|[food]|["COFFEE"-tx-22-"coffee"-noun-0]|TX|5834/6|
00000000|MMI|3.36|Complete|C0205197|[qlco]|["COMPLETE"-tx-20-"complete"-verb-0]|TX|5523/8|
00000000|MMI|3.36|Complication|C0009566|[patf]|["Complications"-tx-7-"Complications"-noun-0]|TX|2695/13|
00000000|MMI|3.36|Cortical Cell Layer of the Cerebellum|C1707522|[tisu]|["Cerebellar"-tx-12-"cerebellar"-adj-0]|TX|3789/10|
00000000|MMI|3.36|Data operation - complete|C3853530|[ftcn]|["complete"-tx-20-"complete"-verb-0]|TX|5523/8|
00000000|MMI|3.36|Digestive System Findings Domain|C3539617|[inpr]|["GI"-tx-17-"GI"-noun-0]|TX|5224/2|
00000000|MMI|3.36|Discharge date|C2361123|[tmco]|["Discharge date"-tx-1-"Discharge Date"-noun-0]|TX|136/14|
00000000|MMI|3.36|Discharge date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative|C2361122|[clna]|["Discharge date"-tx-1-"Discharge Date"-noun-0]|TX|136/14|
00000000|MMI|3.36|Discussion (communication)|C2584313|[socb]|["Discuss"-tx-24-"discuss"-verb-0]|TX|6051/7|
00000000|MMI|3.36|Disease Controlled|C2911690|[fndg]|["Controlled"-tx-5-"Controlled"-verb-0]|TX|2161/10|
00000000|MMI|3.36|Encounter due to family history of colonic polyps|C2911243|[fndg]|["Colonic polyps"-tx-12-"colonic polyps"-noun-0]|TX|3804/14|
00000000|MMI|3.36|Entire head|C1281590|[bpoc]|["Head"-tx-8-"head"-noun-0]|TX|3353/4|
00000000|MMI|3.36|FDA Establishment Activity Terminology|C4049939|[inpr]|["ACTIVITY"-tx-5-"ACTIVITY"-noun-0]|TX|2214/8|
00000000|MMI|3.36|Follow|C1719822|[inpr]|["Follow"-tx-18-"follow"-verb-0]|TX|5364/6|
00000000|MMI|3.36|GNAI1 wt Allele|C1708130|[gngm]|["Gi"-tx-17-"GI"-noun-0]|TX|5224/2|
00000000|MMI|3.36|Gastrointestinal studies and measurements|C4050121|[inpr]|["GI"-tx-17-"GI"-noun-0]|TX|5224/2|
00000000|MMI|3.36|HL7PublishingSubSection <operations>|C3244306|[inpr]|["operations"-tx-7-"OPERATIONS"-noun-0]|TX|2945/10|
00000000|MMI|3.36|Head - Component of Device|C1706305|[mnob]|["Head"-tx-8-"head"-noun-0]|TX|3353/4|
00000000|MMI|3.36|Hypertension Adverse Event|C1963138|[fndg]|["Hypertension"-tx-7-"hypertension"-noun-0]|TX|2742/12|
00000000|MMI|3.36|Hypoxia Adverse Event|C1963140|[fndg]|["HYPOXIA"-tx-17-"hypoxia"-noun-1]|TX|5113/7|
00000000|MMI|3.36|Hysterectomy consent:Finding:Point in time:^Patient:Document|C2360838|[clna]|["Patient"-tx-16-"Patient"-noun-0]|TX|4913/7|
00000000|MMI|3.36|Information|C1533716|[idcn]|["INFORMATION"-tx-4-"information"-noun-0]|TX|1700/11|
00000000|MMI|3.36|Instructions:Text:Point in time:^Patient:Narrative|C3263700|[clna]|["Instructions"-tx-26-"instructions"-noun-0]|TX|6173/12|
00000000|MMI|3.36|Interventional procedure|C0184661|[topp]|["PROCEDURES"-tx-7-"PROCEDURES"-noun-0]|TX|2960/10|
00000000|MMI|3.36|Laboratory test finding|C0587081|[fndg]|["Labs"-tx-19-"labs"-noun-0]|TX|5470/4|
00000000|MMI|3.36|Low cholesterol|C0860920|[fndg]|["Low cholesterol"-tx-5-"low cholesterol"-adj-0]|TX|2192/15|
00000000|MMI|3.36|Manufactured sign|C0220913|[mnob]|["signs"-tx-16-"signs"-noun-0]|TX|4959/5|
00000000|MMI|3.36|Morning|C0332170|[tmco]|["Morning"-tx-22-"morning"-noun-0]|TX|5807/7|
00000000|MMI|3.36|On admission|C0457453|[tmco]|["On admission"-tx-18-"On admission"-adj-0]|TX|5325/12|
00000000|MMI|3.36|PPP4C gene|C1418850|[gngm]|["PPX"-tx-20-"PPx"-noun-0]|TX|5536/3|
00000000|MMI|3.36|PSMD2 gene|C1419032|[gngm]|["S2"-tx-12-"S2"-noun-0]|TX|4355/2|
00000000|MMI|3.36|Percent Activity|C0439167|[qnco]|["% Activity"-tx-5-"ACTIVITY"-noun-0]|TX|2214/8|
00000000|MMI|3.36|Pharmacogenomics Trial Characteristics Domain|C3714755|[inpr]|["PT"-tx-2-"Pt"-noun-0]|TX|939/2|
00000000|MMI|3.36|Physical Activity Measurement|C4049938|[lbpr]|["ACTIVITY"-tx-5-"ACTIVITY"-noun-0]|TX|2214/8|
00000000|MMI|3.36|Physical findings|C0311392|[fndg]|["SIGNS"-tx-16-"signs"-noun-1]|TX|4959/5|
00000000|MMI|3.36|Physical therapy (field)|C0699718|[bmod]|["PT"-tx-2-"Pt"-noun-0]|TX|939/2|
00000000|MMI|3.36|Procedure (set of actions)|C2700391|[acty]|["Procedures"-tx-7-"PROCEDURES"-noun-0]|TX|2960/10|
00000000|MMI|3.36|Pulmonary ventilator management|C1315068|[hlca]|["PULM"-tx-17-"Pulm"-adj-0]|TX|5104/4|
00000000|MMI|3.36|Pump Device Component|C1706421|[mnob]|["Pump"-tx-16-"Pump"-noun-0]|TX|4907/4|
00000000|MMI|3.36|RPS2 gene|C1419718|[gngm]|["S2"-tx-12-"S2"-noun-0]|TX|4355/2|
00000000|MMI|3.36|Radiating to|C0332301|[ftcn]|["radiate"-tx-8-"radiate"-verb-0]|TX|3397/7|
00000000|MMI|3.36|Rate|C1521828|[qnco]|["Rate"-tx-17-"Rate"-noun-0]|TX|5082/4|
00000000|MMI|3.36|Rating (action)|C0871208|[acty]|["Rate"-tx-17-"Rate"-noun-0]|TX|5082/4|
00000000|MMI|3.36|Reaction|C0443286|[ftcn]|["Reaction"-tx-2-"reaction"-noun-0]|TX|976/8|
00000000|MMI|3.36|Resolution|C2699488|[cnce]|["Resolved"-tx-10-"resolved"-verb-0]|TX|3498/8|
00000000|MMI|3.36|Resolved|C3714811|[fndg]|["Resolved"-tx-10-"resolved"-verb-0]|TX|3498/8|
00000000|MMI|3.36|Resolved License|C3897700|[ftcn]|["Resolved"-tx-10-"resolved"-verb-0]|TX|3498/8|
00000000|MMI|3.36|Right sided|C0444532|[spco]|["Right"-tx-12-"right"-noun-0]|TX|3783/5|
00000000|MMI|3.36|S prime|C2603362|[clna]|["S'"-tx-5-"("-noun-0]|TX|2269/1|
00000000|MMI|3.36|S2|C3812876|[fndg]|["S2"-tx-12-"S2"-noun-1]|TX|4355/2|
00000000|MMI|3.36|S2 innervation|C1179705|[blor]|["S2"-tx-12-"S2"-noun-0]|TX|4355/2|
00000000|MMI|3.36|SARCOIDOSIS, SUSCEPTIBILITY TO, 1 (finding)|C2697310|[fndg]|["SARCOIDOSIS"-tx-12-"Sarcoidosis"-noun-0]|TX|3746/11|
00000000|MMI|3.36|SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS SYNDROME|C3542022|[dsyn]|["SOFT"-tx-12-"soft"-adj-1]|TX|4420/4|
00000000|MMI|3.36|See|C1947903|[acty]|["See"-tx-26-"see"-verb-0]|TX|6169/3|
00000000|MMI|3.36|Soft|C0205358|[qlco]|["Soft"-tx-12-"soft"-adj-0]|TX|4420/4|
00000000|MMI|3.36|Sterilization consent:Finding:Point in time:^Patient:Document|C2360840|[clna]|["Patient"-tx-16-"Patient"-noun-0]|TX|4913/7|
00000000|MMI|3.36|Stools:Appearance:Point in time:Lower GI tract:Nominal|C0489144|[clna]|["Stools"-tx-17-"stools"-noun-0]|TX|5251/6|
00000000|MMI|3.36|Supple|C0332254|[ftcn]|["Supple"-tx-12-"supple"-adj-0]|TX|4324/6|
00000000|MMI|3.36|Testicular Cancer Serum Markers Test Result S2|C3812875|[lbtr]|["S2"-tx-12-"S2"-noun-1]|TX|4355/2|
00000000|MMI|3.36|Theobroma cacao, cocoa, chocolate|C0939909|[phsu]|["chocolate"-tx-22-"chocolate"-noun-0]|TX|5852/9|
00000000|MMI|3.36|per second|C0565930|[qnco]|["/s"-tx-5-"("-noun-0]|TX|2269/1|
00000000|MMI|3.36|physiologic resolution|C1514893|[patf]|["Resolved"-tx-10-"resolved"-verb-0]|TX|3498/8|
00000000|MMI|3.36|pump (device)|C0182537|[medd]|["Pump"-tx-16-"Pump"-noun-0]|TX|4907/4|
00000000|MMI|3.36|treatments and procedures|C0237403|[topp]|["treatments procedures"-tx-7-"TREATMENTS/PROCEDURES"-noun-0]|TX|2983/21|
00000000|MMI|2.58|Beginning|C0439659|[tmco]|["Start"-tx-4-"Starting"-verb-0]|TX|1359/8|
00000000|MMI|2.58|Retained|C0333118|[ftcn]|["Keep"-tx-20-"kept"-verb-0]|TX|5503/4|
00000000|MMI|2.45|Patient History|C0679831|[hlca]|["Patient History"-tx-12-"patient's history"-noun-0]|TX|4552/9,4570/7|
00000000|MMI|2.45|Patient history:-:Point in time:^Patient:-|C1369882|[clna]|["Patient history"-tx-12-"patient's history"-noun-0]|TX|4552/9,4570/7|
00000000|MMI|2.44|7 - 9|C3841787|[fndg]|["7 - 9"-tx-15-"7/9"-fraction-0]|TX|4826/3|
00000000|MMI|2.44|Medication.discharge|C0806915|[fndg]|["Discharge medications"-tx-2-"DISCHARGE MEDICATIONS"-noun-0]|TX|457/21|
00000000|MMI|2.44|Nasal Spray|C0461725|[bodm]|["Nasal Spray"-tx-5-"NASAL SPRAY"-noun-0]|TX|1865/11|
00000000|MMI|2.44|Saturated fat|C0597423|[food,orch]|["Saturated fat"-tx-5-"saturated fat"-noun-0]|TX|2178/13|
00000000|MMI|2.41|azotemia pre renal|C0741360|[fndg]|["pre renal azotemia"-tx-18-"pre-renal azotemia"-noun-0]|TX|5403/18|
00000000|MMI|2.40|Codeine allergy|C0009215|[dsyn]|["CODEINE ALLERGY"-tx-12-"Codeine ALLERGIES"-noun-0]|TX|4062/7,4096/9|
00000000|MMI|2.39|50%|C3842586|[fndg]|["50%"-tx-11-"50"-fraction-0]|TX|3538/2|
00000000|MMI|2.39|<50|C3843766|[fndg]|["<50"-tx-11-"50"-fraction-0]|TX|3538/2|
00000000|MMI|2.39|ABD tumor staging notation|C0449202|[inpr]|["ABD"-tx-12-"Abd"-noun-0]|TX|4387/3|
00000000|MMI|2.39|Absence of Biallelic TCRgamma Deletion|C3811055|[comd]|["ABD"-tx-12-"Abd"-noun-1]|TX|4387/3|
00000000|MMI|2.39|Additional comments|C1830770|[fndg]|["Additional comments"-tx-20-"ADDITIONAL COMMENTS"-noun-0]|TX|5587/19|
00000000|MMI|2.39|Anatomic Site|C1515974|[blor]|["Site"-tx-9-"site"-adj-0]|TX|3458/4|
00000000|MMI|2.39|Attending (action)|C1999232|[ftcn]|["attending"-tx-1-"Attending"-noun-0]|TX|372/9|
00000000|MMI|2.39|Attending (provider role)|C1547429|[prog]|["Attending"-tx-1-"Attending"-noun-0]|TX|372/9|
00000000|MMI|2.39|Damage|C1883709|[ftcn]|["Damage"-tx-8-"damage"-noun-0]|TX|3320/6|
00000000|MMI|2.39|Endocrine System Findings Domain|C3538926|[idcn]|["ED"-tx-11-"ED"-noun-0]|TX|3530/2|
00000000|MMI|2.39|GLAUCOMA, NORMAL TENSION, SUSCEPTIBILITY TO (finding)|C1847730|[fndg]|["NTG"-tx-9-"NTG's"-noun-0]|TX|3475/5|
00000000|MMI|2.39|MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME|C3280240|[dsyn]|["MEDS"-tx-12-"MEDS"-noun-0]|TX|3858/4|
00000000|MMI|2.39|Negative - answer|C3853545|[qlco]|["NEG"-tx-17-"neg"-noun-0]|TX|5270/3|
00000000|MMI|2.39|OPA1 gene|C1417953|[gngm]|["NTG"-tx-9-"NTG's"-noun-0]|TX|3475/5|
00000000|MMI|2.39|On (qualifier value)|C1720294|[inpr]|["On"-tx-9-"on"-adj-0]|TX|3455/2|
00000000|MMI|2.39|PSMD3 gene|C1419033|[gngm]|["S3"-tx-12-"S3"-noun-0]|TX|4362/2|
00000000|MMI|2.39|Passenger|C0450048|[popg]|["Passenger"-tx-8-"passenger"-noun-0]|TX|3278/9|
00000000|MMI|2.39|Pharmaceutical Preparations|C0013227|[phsu]|["Medicines"-tx-20-"medicines"-noun-0]|TX|5642/9|D26
00000000|MMI|2.39|RPS3 gene|C1335643|[gngm]|["S3"-tx-12-"S3"-noun-0]|TX|4362/2|
00000000|MMI|2.39|S1|C3715215|[fndg]|["S1"-tx-12-"S1"-noun-1]|TX|4350/2|
00000000|MMI|2.39|S3 (sacral segmental innervation)|C1179706|[blor]|["S3"-tx-12-"S3"-noun-0]|TX|4362/2|
00000000|MMI|2.39|Site|C0205145|[spco]|["Site"-tx-9-"site"-adj-0]|TX|3458/4|
00000000|MMI|2.39|Status|C0449438|[qlco]|["Status"-tx-2-"STATUS"-noun-0]|TX|421/6|
00000000|MMI|2.39|Study Site|C2825164|[spco]|["Site"-tx-9-"site"-adj-0]|TX|3458/4|
00000000|MMI|2.39|Testicular Cancer Serum Markers Test Result S1|C3814877|[lbtr]|["S1"-tx-12-"S1"-noun-1]|TX|4350/2|
00000000|MMI|2.39|Testicular Cancer Serum Markers Test Result S3|C3812877|[lbtr]|["S3"-tx-12-"S3"-noun-1]|TX|4362/2|
00000000|MMI|2.39|Tissue damage|C0010957|[inpo]|["Damage"-tx-8-"damage"-noun-1]|TX|3320/6|
00000000|MMI|2.39|Upon - dosing instruction fragment|C1720176|[ftcn]|["On"-tx-9-"on"-adj-0]|TX|3455/2|
00000000|MMI|2.39|cmH2O|C0439476|[qnco]|["cm H2O"-tx-12-"cm H2O"-noun-0]|TX|4303/6|
00000000|MMI|2.39|day|C0439228|[tmco]|["DAYS"-tx-6-"days"-noun-0]|TX|2440/4|
00000000|MMI|2.37|Report status|C0586177|[fndg]|["Report status"-tx-1-"Report Status"-noun-0]|TX|121/13|
00000000|MMI|2.37|Principal Diagnosis:-:Point in time:^Patient:-|C2598194|[clna]|["Principal Diagnosis"-tx-7-"PRINCIPAL DIAGNOSIS"-noun-0]|TX|2554/9,2574/9|
00000000|MMI|2.37|Principal diagnosis|C0332137|[qlco]|["Principal Diagnosis"-tx-7-"PRINCIPAL DIAGNOSIS"-noun-0]|TX|2554/9,2574/9|
00000000|MMI|2.36|Admission Level of Care Code - Improved|C1561611|[inpr]|["Improved"-tx-19-"improved"-verb-0]|TX|5455/8|
00000000|MMI|2.36|Better|C0332272|[qlco]|["Improved"-tx-19-"improved"-verb-0]|TX|5455/8|
00000000|MMI|2.36|Entered|C1521975|[qlco]|["Entered"-tx-26-"ENTERED"-verb-0]|TX|6206/7|
00000000|MMI|2.36|Improved|C0184511|[qlco]|["Improved"-tx-19-"improved"-verb-0]|TX|5455/8|
00000000|MMI|2.36|Admission date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative|C2598112|[clna]|["Admission date"-tx-1-"Admission Date"-noun-0]|TX|95/14|
00000000|MMI|2.36|Date of admission|C1302393|[tmco]|["Admission date"-tx-1-"Admission Date"-noun-0]|TX|95/14|
00000000|MMI|2.36|Disposition|C0743223|[idcn]|["Disposition"-tx-2-"DISPOSITION"-noun-0]|TX|439/11|
00000000|MMI|2.36|Disposition Domain|C1705555|[inpr]|["Disposition"-tx-2-"DISPOSITION"-noun-0]|TX|439/11|
00000000|MMI|2.36|Entire neck|C1281592|[bpoc]|["Neck"-tx-12-"Neck"-noun-0]|TX|4291/4|
00000000|MMI|2.36|Fluorescence Units|C2348686|[qnco]|["FlU"-tx-20-"Flu"-noun-0]|TX|5559/3|
00000000|MMI|2.36|Focal|C0205234|[spco]|["FOCAL"-tx-12-"focal"-adj-0]|TX|4467/5|
00000000|MMI|2.36|GEN1 gene|C2239486|[gngm]|["Gen"-tx-12-"Gen"-noun-0]|TX|4226/3|
00000000|MMI|2.36|Integumentary scale|C0222045|[bpoc]|["Scales"-tx-20-"scales"-noun-0]|TX|5491/6|
00000000|MMI|2.36|Measurement of fractional excretion of sodium|C0428601|[lbpr]|["FENA"-tx-18-"FeNa"-noun-0]|TX|5378/4|
00000000|MMI|2.36|SAT1 protein, human|C2744672|[aapp,enzy]|["SAT"-tx-12-"Sat"-noun-0]|TX|4215/3|
00000000|MMI|2.36|SAT1 wt Allele|C1705827|[gngm]|["SAT"-tx-12-"Sat"-noun-0]|TX|4215/3|
00000000|MMI|2.36|Saturated|C0522534|[phpr]|["Saturated"-tx-5-"saturated"-noun-0]|TX|2178/9|
00000000|MMI|2.36|Saturated Dosing Unit|C1705188|[qnco]|["SATURATED"-tx-5-"saturated"-noun-0]|TX|2178/9|
00000000|MMI|2.36|Scientific Control|C1882979|[cnce]|["Control"-tx-16-"control"-noun-0]|TX|5072/7|
00000000|MMI|2.36|True Control Status|C3274648|[qlco]|["Control"-tx-16-"control"-noun-0]|TX|5072/7|
00000000|MMI|2.36|Weight measurement scales|C0175659|[medd]|["Scales"-tx-20-"scales"-noun-0]|TX|5491/6|
00000000|MMI|2.36|ZMYND10 wt Allele|C3811318|[gngm]|["FLU"-tx-20-"Flu"-noun-0]|TX|5559/3|
00000000|MMI|2.36|control aspects|C0243148|[qlco]|["control"-tx-16-"control"-noun-0]|TX|5072/7|
00000000|MMI|2.36|control substance|C1550141|[sbst]|["Control"-tx-16-"control"-noun-0]|TX|5072/7|
00000000|MMI|2.36|dendritic spine neck|C3159206|[celc]|["neck"-tx-12-"Neck"-noun-0]|TX|4291/4|
00000000|MMI|2.36|discharge diagnosis|C1555319|[fndg]|["Discharge diagnosis"-tx-7-"DISCHARGE DIAGNOSIS"-noun-0]|TX|2564/19|
00000000|MMI|2.35|60%|C3842585|[fndg]|["60%"-tx-17-"60"-integer-0]|TX|5198/2|
00000000|MMI|2.35|Every evening|C0585330|[tmco]|["QPM"-tx-4-"QPM"-noun-0]|TX|1355/3|
00000000|MMI|2.35|Maxillary right third molar mesial prosthesis|C1552211|[medd]|["1pm"-tx-6-"1pm"-noun-0]|TX|2363/3|
00000000|MMI|2.35|Once a day, in the evening|C1275568|[tmco]|["qPM"-tx-4-"QPM"-noun-0]|TX|1355/3|
00000000|MMI|2.34|Basal Diet|C2983588|[food]|["DIET"-tx-5-"DIET"-noun-0]|TX|2124/4|
00000000|MMI|2.34|Carbohydrates|C0007004|[orch]|["CARBOHYDRATE"-tx-5-"Carbohydrate"-noun-0]|TX|2148/12|D09
00000000|MMI|2.34|Diet (animal life circumstance)|C3668949|[food]|["Diet"-tx-5-"DIET"-noun-0]|TX|2124/4|
00000000|MMI|2.34|Special Diet Therapy|C1519433|[topp]|["DIET"-tx-5-"DIET"-noun-0]|TX|2124/4|
00000000|MMI|2.34|Lying in bed|C0277816|[spco]|["Bed rest"-tx-12-"resting bed"-noun-0]|TX|4251/7,4262/3|
00000000|MMI|2.34|Allergy to sulfonamides|C0038757|[dsyn]|["allergy sulfa"-tx-2-"allergy Sulfa"-noun-0]|TX|958/7,969/5|
00000000|MMI|2.34|IVNS1ABP gene|C1424660|[gngm]|["NS-1"-tx-16-"NS 1"-noun-0]|TX|5008/2,5013/1|
00000000|MMI|2.34|NS-1|C0165193|[orch,phsu]|["NS-1"-tx-16-"NS 1"-noun-0]|TX|5008/2,5013/1|
00000000|MMI|2.34|Test Result|C0456984|[fndg]|["test results"-tx-24-"results test"-noun-0]|TX|6063/7,6079/4|
00000000|MMI|2.33|ActInformationPrivacyReason <service>|C3245478|[idcn]|["service"-tx-1-"Service"-noun-0]|TX|239/7|
00000000|MMI|2.33|Services|C0557854|[ocac]|["Service"-tx-1-"Service"-noun-0]|TX|239/7|
00000000|MMI|2.33|Software Service|C2825316|[mnob]|["Service"-tx-1-"Service"-noun-0]|TX|239/7|
00000000|MMI|2.33|End|C0444930|[spco]|["End"-tx-28-"END"-noun-0]|TX|6276/3|
00000000|MMI|2.33|NPO - Nothing by mouth|C0419179|[topp]|["NPO"-tx-20-"NPO"-noun-0]|TX|5508/3|
00000000|MMI|2.33|Responsible to|C1273518|[fndg]|["Responsible"-tx-7-"Responsible"-adj-0]|TX|2585/11|
00000000|MMI|2.33|Started|C1272689|[qlco]|["Started"-tx-11-"started"-verb-0]|TX|3576/7|
00000000|MMI|2.33|Stop (qualifier value)|C2746065|[tmco]|["End"-tx-28-"END"-noun-0]|TX|6276/3|
00000000|MMI|2.33|seen|C0205397|[qlco]|["Seen"-tx-9-"seen"-verb-0]|TX|3443/4|
00000000|MMI|2.32|Senokot Tablets|C1616946|[clnd]|["Senokot Tablets"-tx-4-"SENNA TABLETS"-noun-0]|TX|1276/13|
00000000|MMI|2.32|10 Hours|C1442445|[tmco]|["10 Hours"-tx-22-"hours 10"-noun-0]|TX|5895/5,5908/2|
00000000|MMI|2.32|Conditional|C1701901|[qlco]|["Contingent"-tx-1-"CONTINGENT"-noun-0]|TX|294/10|
00000000|MMI|2.32|Covered (qualifier value)|C0439844|[ftcn]|["covering"-tx-6-"covering"-noun-0]|TX|2328/8|
00000000|MMI|2.32|Covers (device)|C0180153|[medd]|["covering"-tx-6-"covering"-noun-0]|TX|2328/8|
00000000|MMI|2.32|HEENT|C1512338|[blor]|["HEENT"-tx-12-"HEENT"-noun-0]|TX|4266/5|
00000000|MMI|2.32|Hospital environment|C1510665|[qlco]|["Hospital"-tx-20-"hospital"-noun-0]|TX|5685/8|
00000000|MMI|2.32|Imaging Techniques|C0079595|[diap]|["Imaging"-tx-15-"imaging"-verb-0]|TX|4798/7|
00000000|MMI|2.32|Increased sweating|C0700590|[sosy]|["DIAPHORESIS"-tx-8-"diaphoresis"-noun-0]|TX|3421/11|
00000000|MMI|2.32|NADPH:sulfur oxidoreductase activity|C2700623|[moft]|["NSR"-tx-17-"NSR"-noun-0]|TX|5088/3|
00000000|MMI|2.32|Neutral Sidebent Rotated|C1704493|[patf]|["NSR"-tx-17-"NSR"-noun-0]|TX|5088/3|
00000000|MMI|2.32|Patient Class - Outpatient|C1549405|[clas]|["Outpatient"-tx-15-"outpatient"-noun-0]|TX|4812/10|
00000000|MMI|2.32|R prime|C2603358|[clna]|["R'"-tx-7-"R"-noun-0]|TX|3016/1|
00000000|MMI|2.32|Referral category - Outpatient|C1548439|[idcn]|["Outpatient"-tx-15-"outpatient"-noun-0]|TX|4812/10|
00000000|MMI|2.32|Tender|C0234234|[qlco]|["Tender"-tx-12-"tender"-noun-0]|TX|4392/6|
00000000|MMI|2.31|Allergic disposition|C3539909|[dsyn]|["Allergy"-tx-7-"ALLERGY"-noun-0]|TX|2488/7|
00000000|MMI|2.31|Allergy - Physicians|C1554743|[prog]|["Allergy"-tx-7-"ALLERGY"-noun-0]|TX|2488/7|
00000000|MMI|2.31|Dry|C0205222|[qlco]|["Dry"-tx-16-"dry"-adj-0]|TX|4925/3|
00000000|MMI|2.31|Dryness (characteristic)|C1512080|[qlco]|["Dry"-tx-16-"dry"-adj-0]|TX|4925/3|
00000000|MMI|2.31|Response to antigens|C1314973|[phsf]|["ALLERGY"-tx-7-"ALLERGY"-noun-0]|TX|2488/7|
00000000|MMI|2.31|Place|C0442504|[spco]|["Place"-tx-13-"placed"-verb-0]|TX|4672/6|
00000000|MMI|2.31|Place - dosing instruction imperative|C1704765|[ftcn]|["Place"-tx-13-"placed"-verb-0]|TX|4672/6|
00000000|MMI|2.31|put - instruction imperative|C1882509|[acty]|["Place"-tx-13-"placed"-verb-0]|TX|4672/6|
00000000|MMI|2.31|*Velocity|C1547053|[qnco]|["*Velocity"-tx-8-"velocity"-noun-0]|TX|3252/8|
00000000|MMI|2.31|Motor vehicle accident|C2939181|[phpr]|["MVA"-tx-8-"MVA"-noun-0]|TX|3261/3|
00000000|MMI|2.31|Slow|C0439834|[qlco]|["Slow"-tx-8-"slow"-adj-0]|TX|3247/4|
00000000|MMI|2.31|Used by|C1273517|[fndg]|["used"-tx-1-"USED"-verb-1]|TX|343/4|
00000000|MMI|2.31|Velocity|C0439830|[qnco]|["Velocity"-tx-8-"velocity"-noun-0]|TX|3252/8|
00000000|MMI|2.30|Bounded by|C0332297|[spco]|["BB"-tx-13-"BB"-noun-0]|TX|4651/2|
00000000|MMI|2.30|Inferior|C0542339|[spco]|["Sub-"-tx-11-"sub"-adj-0]|TX|3632/3|
00000000|MMI|2.30|Regimen - CHV concept|C2945654|[inpr]|["regimen"-tx-13-"regimen"-noun-0]|TX|4640/7|
00000000|MMI|2.30|Substance amount|C1264637|[qnco]|["SUB"-tx-11-"sub"-adj-0]|TX|3632/3|
00000000|MMI|2.30|Therapeutic|C0302350|[ftcn]|["Therapeutic"-tx-11-"therapeutic"-adj-0]|TX|3636/11|E02
00000000|MMI|2.30|Card (document)|C3275277|[inpr]|["Card"-tx-23-"card"-noun-0]|TX|5941/4|
00000000|MMI|2.30|Naproxen 500 MG|C0987999|[clnd]|["Naproxen 500 MG"-tx-12-"Naprosyn 500 MG"-noun-0]|TX|3864/15|
00000000|MMI|2.30|Sint Maarten (Dutch Part)|C3539997|[geoa]|["SXM"-tx-16-"sxms"-noun-0]|TX|4968/4|
00000000|MMI|2.29|Aspirin 325 MG|C0992015|[clnd]|["Acetylsalicylic Acid 325 MG"-tx-2-"ACETYLSALICYLIC ACID 325 MG"-noun-0]|TX|480/27|
00000000|MMI|2.29|Doctor of Chiropractic|C1512015|[inpr]|["D.C."-tx-1-"D/C"-noun-0]|TX|330/3|
00000000|MMI|2.28|Concern|C2699424|[idcn]|["Concern"-tx-7-"concerning"-noun-0]|TX|3150/10|
00000000|MMI|2.27|CETRIMONIUM BROMIDE|C0951233|[hops,orch]|["CTAB"-tx-12-"CTAB"-noun-0]|TX|4382/4|
00000000|MMI|2.27|Causing|C0678227|[ftcn]|["Causing"-tx-7-"Causing"-adj-0]|TX|2613/7|
00000000|MMI|2.27|Diagnosis Type - Final|C1546485|[idcn]|["Final"-tx-1-"FINAL"-adj-0]|TX|169/5|
00000000|MMI|2.27|Distant|C0443203|[spco]|["DISTANT"-tx-12-"distant"-adj-0]|TX|4342/7|
00000000|MMI|2.27|End-stage|C0205088|[qlco]|["Final"-tx-1-"FINAL"-adj-0]|TX|169/5|
00000000|MMI|2.27|FAM3A gene|C1422181|[gngm]|["2-19"-tx-6-"2/19"-fraction-0]|TX|2354/4|
00000000|MMI|2.27|Final|C3853528|[tmco]|["Final"-tx-1-"FINAL"-adj-0]|TX|169/5|
00000000|MMI|2.27|MAS1L gene|C1422304|[gngm]|["MRG"-tx-12-"MRG"-noun-0]|TX|4372/3|
00000000|MMI|2.27|New|C0205314|[qlco]|["NEW"-tx-18-"new"-adj-0]|TX|5346/3|
00000000|MMI|2.27|Physical|C0205485|[ftcn]|["Physical"-tx-8-"physical"-adj-0]|TX|3311/8|
00000000|MMI|2.27|Physical assessment findings|C1509143|[fndg]|["Physical"-tx-8-"physical"-adj-1]|TX|3311/8|
00000000|MMI|2.27|Yes (indicator)|C1705108|[cnce]|["YES"-tx-1-"YES"-noun-0]|TX|368/3|
00000000|MMI|2.27|Yes - Yes/no indicator|C1549445|[idcn]|["Yes"-tx-1-"YES"-noun-0]|TX|368/3|
00000000|MMI|2.27|dictated - DocumentCompletion|C1609990|[idcn]|["Dictated"-tx-26-"dictated"-adj-0]|TX|6189/8|
00000000|MMI|2.27|dictated - ParticipationMode|C1548384|[ftcn]|["dictated"-tx-26-"dictated"-adj-0]|TX|6189/8|
00000000|MMI|2.26|Codeine Phosphate 30 MG|C2917839|[clnd]|["Codeine Phosphate 30 MG"-tx-2-"CODEINE PHOSPHATE 30 MG"-noun-0]|TX|705/23|
00000000|MMI|2.26|Vitamin K Drug Class|C3714648|[phsu,vita]|["VITAMIN K"-tx-4-"Vitamin-K"-noun-0]|TX|1449/9|
00000000|MMI|2.26|Vitamin K [EPC]|C2936884|[phsu]|["Vitamin K"-tx-4-"Vitamin-K"-noun-0]|TX|1449/9|
00000000|MMI|2.26|Vitamin K containing hemostatics|C3541380|[orch,phsu,vita]|["Vitamin K"-tx-4-"Vitamin-K"-noun-0]|TX|1449/9|
00000000|MMI|2.26|Congestive heart failure|C0018802|[dsyn]|["Heart Failure"-tx-16-"heart failure"-noun-1]|TX|4976/13|
00000000|MMI|2.26|1-2|C3843716|[fndg]|["1-2"-tx-5-"1-2"-integer-0]|TX|1879/3|
00000000|MMI|2.26|1/2|C0580272|[inpr]|["1/2"-tx-5-"1-2"-integer-0]|TX|1879/3|
00000000|MMI|2.26|70%|C3842584|[fndg]|["70%"-tx-12-"70"-fraction-0]|TX|4202/2|
00000000|MMI|2.26|Administration procedure|C1533734|[topp]|["Treatment"-tx-7-"Treatment"-noun-0]|TX|2721/9|
00000000|MMI|2.26|Anicteric|C0205180|[fndg]|["Anicteric"-tx-12-"anicteric"-adj-0]|TX|4273/9|
00000000|MMI|2.26|Axial R|C3538806|[spco]|["Ra"-tx-12-"RA"-noun-0]|TX|4223/2|
00000000|MMI|2.26|Biomaterial Treatment|C1705169|[cnce]|["Treatment"-tx-7-"Treatment"-noun-0]|TX|2721/9|
00000000|MMI|2.26|Cardiac - anatomy qualifier|C1522601|[spco]|["Cardiac"-tx-12-"cardiac"-adj-0]|TX|4562/7|
00000000|MMI|2.26|Checking (action)|C1283174|[acty]|["Check"-tx-18-"check"-noun-0]|TX|5372/5|
00000000|MMI|2.26|Cheque|C1555524|[mnob]|["Cheque"-tx-18-"check"-noun-0]|TX|5372/5|
00000000|MMI|2.26|Data Validation Test Document|C3899446|[inpr]|["DVT"-tx-12-"DVT"-noun-0]|TX|3719/3|
00000000|MMI|2.26|Ever told by doctor that you had deep venous thrombosis:Finding:Point in time:^Patient:Ordinal|C2926618|[clna]|["DVT"-tx-12-"DVT"-noun-0]|TX|3719/3|
00000000|MMI|2.26|Good|C0205170|[qlco]|["Good"-tx-16-"good"-adj-0]|TX|5064/4|
00000000|MMI|2.26|HPX wt Allele|C3814444|[gngm]|["HX"-tx-13-"hx"-noun-0]|TX|4700/2|
00000000|MMI|2.26|K Prime|C1708601|[qnco]|["K'"-tx-20-"K"-noun-0]|TX|5486/1|
00000000|MMI|2.26|Phase I/II Trial|C1519043|[resa]|["1-2"-tx-5-"1-2"-integer-0]|TX|1879/3|
00000000|MMI|2.26|Potassium Ion|C0597277|[elii,phsu]|["K+"-tx-20-"K"-noun-0]|TX|5486/1|
00000000|MMI|2.26|Regular exercise (observable entity)|C0582191|[dora]|["Regular exercise"-tx-5-"regular exercise"-noun-0]|TX|2231/16|
00000000|MMI|2.26|Right arm|C4048756|[bpoc]|["RA"-tx-12-"RA"-noun-0]|TX|4223/2|
00000000|MMI|2.26|Suspicion|C0242114|[menp]|["SUSPICION"-tx-17-"suspicion"-noun-1]|TX|5127/9|
00000000|MMI|2.26|Treating|C1522326|[ftcn]|["Treatment"-tx-7-"Treatment"-noun-0]|TX|2721/9|
00000000|MMI|2.26|Treatment Epoch|C3538994|[resa]|["TREATMENT"-tx-7-"Treatment"-noun-0]|TX|2721/9|
00000000|MMI|2.26|treatment - ActInformationManagementReason|C3887704|[hlca]|["treatment"-tx-7-"Treatment"-noun-0]|TX|2721/9|
00000000|MMI|2.25|97|C0439073|[inpr]|["97"-tx-12-"97"-real_number-0]|TX|4183/2|
00000000|MMI|2.25|>97|C0439082|[qnco]|[">97"-tx-12-"97"-real_number-0]|TX|4183/2|
00000000|MMI|2.25|Jugular venous engorgement|C0425687|[fndg]|["JVD"-tx-12-"JVD"-noun-0]|TX|4297/3|
00000000|MMI|2.25|Patient Condition Code - Stable|C1547311|[inpr]|["Stable"-tx-26-"Stable"-adj-0]|TX|6143/6|
00000000|MMI|2.25|Stable status|C0205360|[qlco]|["STABLE"-tx-26-"Stable"-adj-0]|TX|6143/6|
00000000|MMI|2.25|T prime|C2603360|[clna]|["T'"-tx-12-"T"-noun-0]|TX|4181/1|
00000000|MMI|2.25|Nasal congestion (finding)|C0027424|[sosy]|["NASAL CONGESTION"-tx-5-"nasal congestion"-noun-0]|TX|1905/16|
00000000|MMI|2.25|+2|C0740116|[qnco]|["+2"-tx-4-"2"-integer-0]|TX|1305/1|
00000000|MMI|2.25|2+|C3833492|[fndg]|["2+"-tx-4-"2"-integer-0]|TX|1305/1|
00000000|MMI|2.25|2+ Score|C2827735|[qnco]|["2+"-tx-4-"2"-integer-0]|TX|1305/1|
00000000|MMI|2.25|2+ Score, WHO|C2981700|[clas]|["2+"-tx-4-"2"-integer-0]|TX|1305/1|
00000000|MMI|2.25|Abnormally high|C1299351|[qlco]|["High"-tx-4-"high"-adj-0]|TX|1444/4|
00000000|MMI|2.25|Contain (action)|C2700400|[acty]|["Containing"-tx-4-"containing"-adj-0]|TX|1459/10|
00000000|MMI|2.25|Containing (qualifier)|C0332256|[ftcn]|["Containing"-tx-4-"containing"-adj-0]|TX|1459/10|
00000000|MMI|2.25|High|C0205250|[qlco]|["High"-tx-4-"high"-adj-0]|TX|1444/4|
00000000|MMI|2.25|High Mitosis-Karyorrhexis Index|C3889660|[qnco]|["High"-tx-4-"high"-adj-0]|TX|1444/4|
00000000|MMI|2.25|House (environment)|C2003847|[mnob]|["House"-tx-5-"House"-noun-0]|TX|2130/5|
00000000|MMI|2.25|Only - dosing instruction fragment|C1720467|[inpr]|["Only"-tx-18-"only"-adv-0]|TX|5398/4|
00000000|MMI|2.25|Probable diagnosis|C0332148|[qlco]|["Likely"-tx-18-"likely"-adv-0]|TX|5391/6|
00000000|MMI|2.25|Probably|C0750492|[idcn]|["Likely"-tx-18-"likely"-adv-0]|TX|5391/6|
00000000|MMI|2.25|Singular|C0205171|[qnco]|["Only"-tx-18-"only"-adv-0]|TX|5398/4|
00000000|MMI|2.25|Value Above Reference Range|C2700149|[inpr]|["HIGH"-tx-4-"high"-adj-0]|TX|1444/4|
00000000|MMI|2.25|high - ActExposureLevelCode|C3887512|[idcn]|["high"-tx-4-"high"-adj-0]|TX|1444/4|
00000000|MMI|2.24|Diagnostic interview schedule|C0451119|[inpr]|["DIS"-tx-1-"DIS"-noun-0]|TX|89/3|
00000000|MMI|2.24|Primary|C0205225|[qlco]|["Principal"-tx-7-"PRINCIPAL"-adj-0]|TX|2554/9|
00000000|MMI|2.24|Teaching principal|C0401925|[prog]|["Principal"-tx-7-"PRINCIPAL"-adj-0]|TX|2554/9|
00000000|MMI|2.24|mEq|C0439152|[qnco]|["mEq"-tx-12-"MEQ"-noun-0]|TX|3913/3|
00000000|MMI|2.24|Cleaning (activity)|C1947930|[acty]|["Clean"-tx-7-"clean"-adj-0]|TX|3187/5|
00000000|MMI|2.24|30%|C3842588|[fndg]|["30%"-tx-12-"30"-integer-0]|TX|4074/2|
00000000|MMI|2.24|Ani (bird)|C0326040|[bird]|["Ani"-tx-1-"Ani"-noun-0]|TX|232/3|
00000000|MMI|2.24|Every four hours|C0585324|[tmco]|["Q4H"-tx-2-"Q4H"-noun-0]|TX|732/3|
00000000|MMI|2.24|Physical restraint equipment (device)|C0337184|[medd]|["Restraints"-tx-8-"restrained"-adj-0]|TX|3267/10|
00000000|MMI|2.24|Restraints:-:Point in time:^Patient:-|C2708180|[clna]|["Restraints"-tx-8-"restrained"-adj-0]|TX|3267/10|
00000000|MMI|2.24|Room of building - Study|C0557651|[mnob]|["Study"-tx-7-"Study"-noun-0]|TX|2603/5|
00000000|MMI|2.24|Study|C2603343|[resa]|["Study"-tx-7-"Study"-noun-0]|TX|2603/5|
00000000|MMI|2.24|PRN medicine|C3166225|[clna]|["PRN Drugs"-tx-4-"PRN Drug"-noun-0]|TX|1218/3,1232/4|
00000000|MMI|2.23|CXADR wt Allele|C3540475|[gngm]|["CAR"-tx-1-"CAR"-noun-0]|TX|248/3|
00000000|MMI|2.23|Coxsackievirus and Adenovirus Receptor|C3539542|[aapp]|["CAR"-tx-1-"CAR"-noun-0]|TX|248/3|
00000000|MMI|2.23|Infusion pump Alert priority PM|C4049155|[fndg]|["PM"-tx-1-"PM"-adj-0]|TX|291/2|
00000000|MMI|2.23|NR1I3 wt Allele|C3811749|[gngm]|["CAR"-tx-1-"CAR"-noun-0]|TX|248/3|
00000000|MMI|2.23|TCAP gene|C1420621|[gngm]|["TELE"-tx-17-"tele"-noun-0]|TX|5095/4|
00000000|MMI|2.23|Telephone Number|C1515258|[cnce]|["Tele"-tx-17-"tele"-noun-0]|TX|5095/4|
00000000|MMI|2.23|recurrent Chest Pains|C2169796|[sosy]|["recurrent Chest Pain"-tx-7-"recurrent chest pain"-noun-0]|TX|3129/20|
00000000|MMI|2.23|Firstly|C1279901|[qlco]|["Initial"-tx-16-"initial"-adj-0]|TX|4932/7|
00000000|MMI|2.23|Initial (abbreviation)|C1555582|[idcn]|["Initial"-tx-16-"initial"-adj-0]|TX|4932/7|
00000000|MMI|2.23|Initial Usage|C1705685|[ftcn]|["INITIAL"-tx-16-"initial"-adj-0]|TX|4932/7|
00000000|MMI|2.23|Initially|C0205265|[tmco]|["Initial"-tx-16-"initial"-adj-0]|TX|4932/7|
00000000|MMI|2.23|Possible|C0332149|[qlco]|["Possible"-tx-2-"POSSIBLE"-adj-0]|TX|949/8|
00000000|MMI|2.23|Possible diagnosis|C2362652|[qlco]|["Possible"-tx-2-"POSSIBLE"-adj-0]|TX|949/8|
